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Diabetes mellitus is a chronic disease that affects millions of people in the United States. The 
purpose of this project was to develop a guideline to help clinical staff provide clear and concise 
diabetes self-management instructions to patients in a community setting. Orem’s self-care 
deficit theory (SCD) and health belief model (HBM) provided a platform to assess how patients’ 
self-care deficit contributes to illness and the effect of patients’ perception of illness. SCD theory 
and the HBM provided the framework for the development of the guideline to decrease diabetes 
acute complications through self-management education. The practice-focused question was 
whether the diabetes treatment guideline would decrease diabetes complication, improve the 
quality of care received by the diabetic patients, and if the facility would adopt the developed 
guideline. AGREE II Tool was used to assess the quality of the guideline and the staffs’ desire 
for the adoption of the guideline. Data were collected from questionnaires given to staff 
members at the practice site in 2 rounds. Six medical staff were asked to critique the initial 
guideline, and 5 medical professionals were asked to assess the final guideline. Most of the 
participants’ scores indicated strong agreement that full consideration was met. The score in all 6 
AGREE II domains was above 90%, and 100% of the participants recommended the guideline to 
be adopted in the facility. Data analysis indicated the diabetes practice guideline is valid, will 
enhance the treatment of diabetes, and the practice site employees were eager to adopt the 
treatment guideline. Findings may be used to increase population health and reduce acute 
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Section 1: Nature of the Project 
The clinic site for this project is a family medicine clinic located in a low-
income neighborhood; the clinic sees 30-40 patients daily. Most residents who attend 
the clinic are fixed-income retirees who are Social Security beneficiaries, and the 
major sources of health insurance coverage are Medicare, Medicaid, and the 
Affordable Care Act, popularly known as Obamacare. Most children who attend the 
clinic are on the Texas Children Health Insurance Program. The practice site has 
many patients with the diagnosis of diabetes mellitus (DM). DM can be debilitating 
and can incapacitate when complications develop. The physiological effects of 
diabetes are related to the adverse health effects of hyperglycemia (Chrvala, Sherr, 
and Lipman, 2016). Many patients do not appreciate the health hazards that diabetes 
poses until late in the disease process, when complications have developed, and the 
disease has advanced to a point of causing organ failure. 
Staff at the clinic do not have sufficient time to teach patients the desired 
skills because they are limited to 15-20 minutes per patient for health history, 
physical examination, diagnosis, and treatment; not enough time is devoted to 
teaching and demonstrating the skills that diabetes patients will need to manage their 
health care needs. Because of the infrequent teaching and insufficient reinforcement 
of diabetes management education, many patients have hyperglycemia. When the 
clinic staff conduct teaching, they do not follow the diabetes management protocol. 
The role of the health care provider in diabetes management should be to decrease the 
effects of diabetes on the patients. Diabetes self-care, when combined with 





decreasing diabetes complications (Chrvala et al., 2016). Deakin, McShane, Cade, 
and Williams (2005) conducted a meta-analysis of 11 studies with 1,532 participants 
and found that group-based training for self-management strategies in people with 
type 2 diabetes was effective at improving fasting blood glucose levels, glycosylated 
hemoglobin, and diabetes knowledge and in reducing systolic blood pressure, body 
weight, and the requirement for diabetes medication. The goal of this project was to 
develop an evidence-based guideline for diabetes management at the project site. The 
guideline is supported by diabetes self-management education to increase knowledge 
of the project site staff in managing diabetes and improving patients’ behaviors to 
reduce diabetes-associated acute complications. This project will provide patients 
with the tools, skills, and knowledge to prevent or delay the development of diabetes 
complications.  
The diabetes care standards developed by the American Diabetes Association 
(ADA, 2016a) specify multifactor care with risk reduction strategies that go beyond 
monitoring serum glucose values. The ADA (2016a) states that ongoing patient-
oriented self-management education and supportive care are critical to preventing 
acute complications and reducing the risk of long-term complications. When a 
diabetes self-management program is instituted early in the management of diabetes, 
complications are kept at bay, and in some cases diabetes and its associated 
complications can be reversed when combined with dietary modification (Power, 
Bardsley, Cypress, Duker, and Funnell, 2015). Diabetes self-management guidelines 
provide the opportunity for patients, clinicians, community members, and researchers 





evaluate outcomes. Diabetes self-management education is a tool to improve diabetes 
and its associated complications, but it does not preclude clinical judgment; diabetes 
patients’ preferences, cultural inclinations, and family dynamics must be factored into 
treatment plans and applied in the best available clinical care. Patients’ preferences, 
inclinations, and educational capacities must be considered to ensure compliance with 
treatment plans. The guideline I developed for this study included consideration of 
the demographics of the diabetes patients who attend the practice site. 
Problem Statement 
The social and economic impacts of DM are considerable. Nearly 30 million 
Americans have diabetes, and 1 in 3 Medicare dollars is spent caring for people with 
diabetes and that result to diabetes and prediabetes costing Americans $322 billion 
per year, and 1 in 5 health care dollars is spent caring for people with diabetes (ADA, 
2016b). The long-term economic and social impacts of the intervention for this study 
will manifest as fewer limb amputations, fewer diabetes complications such as 
retinopathy and associated blindness, and fewer instances of end-stage renal disease, 
which is responsible for high rates of dialysis. Brown et al. (2013) concluded that 
most diabetes-related medical costs stem from complications and comorbidities; 
Brown et al. indicated that preventing end-stage renal disease could save 300% to 
500% through avoidance of kidney transplant. Savings from cardiovascular events 
such as coronary heart disease and congestive heart failure, as well as hemiplegia and 
limb amputations, would be 70% to 150% (Brown et al., 2013). Herman (2012) stated 
that 360% savings could be derived from preventing stroke, myocardial infarction, 





study will be to increase diabetes patient self-management and decrease 
hyperglycemia and acute kidney disease. The long-term goal of diabetes management 
is to decrease the prevalence of diabetes and its associated complications and lower 
the social cost of managing diabetes complications (Chrvala et al., 2016). 
The local need to address the complications of DM arose from the fact that 
large segments of the population who attend the clinic that was the site for this study 
have one or multiple diabetes complications that could have been prevented. Most 
patients who attend the clinic are elderly and do not have the basic education to 
comprehend the medical implications of not taking control of their health issues. Not 
adequately controlling diabetes could escalate to serious medical conditions that 
could result in considerable socioeconomic burden to patients and the community. 
Because diabetes complications can be prevented, it is prudent to institute a diabetes 
self-management program at the practice site. A review of practice site patients’ 
medical records from 2012 to the present revealed that 75% of patients have a 
diagnosis of diabetes and have one or more diagnoses of chronic diseases such as 
hyperlipidemia, hypertension, and chronic kidney disease associated with diabetes. 
The more comorbidities the patients have, the more complicated the task of 
controlling their diabetes. About 15% of the patients have prediabetes.  
The significance of establishing an evidence-based diabetes guideline is that 
the treatment at the practice site will be channeled toward an effective and 
standardized health care management protocol that would alleviate the burden of 
diabetes complications. There is no current treatment protocol for diabetes 





suits his or her preferences. This treatment pattern often leads to patients having 
uncontrolled HgA1C and fasting glucose serum levels, while other patients may 
experience hypoglycemia because of overmedication with sulfonylurea, insulin, and 
other hypoglycemia drugs such as metformin. In some cases, patients are not being 
treated at the initial manifestation of diabetes; instead the providers wait to see if the 
patients’ glucose levels will return to normal. This approach works sometimes, but 
other times patients proceed to a symptomatic state and develop profound and 
uncontrolled hyperglycemia, dehydration due to polyuria, stage III chronic kidney 
disease, decreased vision, and foot ulcers. Establishing a diabetes treatment protocol 
at the practice site may improve the diabetes management at the clinic.  
The ADA supports diabetes management protocols that emphasize self-
management education aimed at preventing complications; the ADA recommended 
that diabetes self-management education be incorporated in diabetes treatment. The 
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK, 2014) 
supports this and also recommends that diabetes patients maintain glucose levels 
within the normal range of HgA1c of 5.7% to 6.4%, which could be achieved with a 
diabetes self-management education protocol. Haas et al. (2012) noted that self-
management is a critical element of care for people with diabetes and is necessary to 
prevent or delay complications. Other researchers have also supported diabetes 
management (Chen, Creedy, Lin, & Wollin, 2012; Sieber, Newsome, & Lillie, 2012; 
Tsiananga et al., 2012). In order for the practice site to manage diabetes patients’ 
glucose levels and reduce diabetes complications, a comprehensive diabetes self-






The primary purpose of this project was to develop a diabetes guideline to 
improve diabetes patient self-management through education of staff and patients in 
the practice setting, a clinic in Texas. The secondary purpose was to raise awareness 
of the importance of adopting the diabetes self-management protocol. Diabetes 
management skills may decrease the prevalence of diabetes complications by 
enabling staff to initiate diabetes treatment in accordance with the protocol and 
equipping patients with knowledge to take ownership of their health care needs and 
follow their treatment plans. The gap in practice that I addressed with this evidence-
based project was the lack of a uniform diabetes guideline to control fasting serum 
levels, normalize HgA1C, and prevent diabetes complications. The at-risk population, 
25- to 80-year-old diabetes patients, receives routine care at the clinic based on the 
discretion of the staff’s treatment style, but the care is not based on an established 
guideline. A consistent approach was needed to reduce complications, improve 
patients’ health status, and allow patients to live normal lives. The practice-focused 
questions for establishing a guideline for diabetes self-management education at the 
practice site were the following: 
• Will implementing a diabetes guideline based on the concept of diabetes 
self-management education result in improved fasting serum and Hga1c 
levels among diabetes patients? 
• Will a diabetes guideline increase the staff’s awareness of the effective 





• Will the staff adhere to a diabetes guideline to maintain consistency of 
care for diabetes patients? 
• Will a diabetes guideline improve patients’ self-management of their 
diabetes? 
• Will a diabetes guideline based on diabetes self-management education 
prevent diabetes complications?  
Developing an evidence-based clinical practice guideline for teaching patients 
the essential skills for managing their diabetes care needs requires dedication from the 
patients as well as from the providers; it is a collaborative effort that requires patients 
to show commitment to the treatment plan. The providers also need to motivate 
patients to comply; staff efforts to motivate patients to follow the treatment plan may 
include encouraging patients to perform serum glucose checks at least once a day 
before eating, record their glucose levels for review at the office visit, make lifestyle 
changes, modify their diets, and take their medications as instructed. Diabetes self-
management skills may improve patients’ ability to control their serum glucose levels 
and may improve their self-image, physical agility, and emotional well-being. The 
gap in routine diabetes care practice that accounts for the high prevalence of diabetes 
complications at the practice site can be bridged by developing and implementing an 
evidence-based diabetes self-management program to educate patients and enhance 
their ability to control their diabetes and avoid complications. 
Nature of the Doctoral Project 
The sources of evidence to satisfy the purpose of the doctoral project included 





Cochrane. Other sources of evidence were websites of the Centers for Disease 
Control and Prevention (CDC), the ADA, the NIDDK, and the American Academy of 
Nutrition and Dietetics. Most of the sources were found in the Walden University 
library. Sources included empirical studies, meta-analyses, and expert opinions on the 
subject.  
It was also necessary to evaluate the staff’s knowledge of diabetes guidelines 
even though guidelines are not used at the project site. The Appraisal of Guideline for 
Research & Evaluation (AGREE II) instrument was used to validate the guideline. 
The AGREE II instrument has been used in developing guidelines to improve 
patients’ health outcomes, and it assisted in developing the evidence-based guideline 
for this study, ensuring that the guideline met the criterion of improving patients’ 
health outcomes at the practice site. The data highlighted the gap in practice and 
affirmed the need to establish a guideline for treating diabetes patients based on 
diabetes self-management education (Browers, Mellissa, and Kerkvliet, 2016).  
Significance of the Project 
DM is a chronic and debilitating disease that has the potential to overwhelm 
patients when complications develop. Jack, Liburd, Tucker, and Cockrell (2014) 
noted that managing diabetes requires collaborative care between the patient and the 
primary care provider. Diabetes treatment guidelines that encourage health care 
providers to implement a collaborative approach may enhance patient cooperation 
and give the patient much-needed support. The stakeholders who should be involved 
are primary care providers, consultants, diabetes organizations such as the ADA and 





and friends, local health care facilities, and community entrepreneurs. Each of the 
stakeholders has a role to play in diabetes management and funding programs aimed 
at decreasing the prevalence of diabetes and its associated complications. Well-
known organizations such as the ADA and the Academy of Nutrition and Dietetics 
that advocate for effective diabetes programs play an active role in communities to 
increase awareness of diabetes and its associated complications. Local diabetes 
support groups are stakeholders who provide emotional support to relieve stress and 
inform patients that they are not alone in the fight against diabetes. Patients’ friends 
and family members are also valuable sources of support and encouragement. A team 
approach to diabetes management includes comprehensive assessment and plans to 
address patients’ values and circumstances (ADA, 2016a).  
In 2015, American Academy of Nutrition and Dietetics noted that Dietary 
modification is an essential component of managing diabetes. Incorporating the diet 
recommendations of the ADA will enhance the effectiveness of diabetes self-
management education and training. Guidelines from the American Academy of 
Nutrition and Dietetics (2015) focus on nutrition assessment, nutrition interventions, 
and nutrition monitoring and evaluation to promote positive clinical outcomes for 
patients with type 1 and type 2 diabetes. The input of stakeholders such as local 
organizations, educational institutions, and business leaders should be sought to 
address diabetes in the community.  
Consistent education about diabetes self-management and the complications 
associated with uncontrolled serum glucose levels may help to increase patients’ 





shown that patients who are compliant with diabetes self-management education 
show dramatically fewer diabetes complications (Shrivastana, Shrivastana, & 
Ramasamy, 2013). Patients’ knowledge and active participation in their care is a key 
ingredient in being compliant with medical treatment. Appold (2016) suggested that 
health care providers who maintain cordial professional relationships with patients 
facilitate compliance. A diabetes practice guideline should contain recommendations 
on removing patients’ barriers to adherence to treatment plans. Programs designed to 
decrease the prevalence of diabetes should increase awareness among community 
members regarding the adverse effects of diabetes and the types of assistance 
community members could provide to support the program. 
 Establishing a diabetes guideline at the project site for this study was the first 
step in decreasing diabetes complications among patients who attend the clinic. 
Implications for positive change in diabetes self-management include decreasing 
patients’ economic burden, increasing patients’ productivity, improving patients’ 
quality of life, and decreasing hospitalizations. In 2014, 14.2 million emergency 
department visits were reported with diabetes as a listed diagnosis among adults aged 
18 years or older, and 7.2 million hospital discharges were reported with diabetes-
related outcomes that included limb amputation, renal failure, stroke, and ischemic 
heart disease (CDC, 2017). Patients with DM may have short life spans due to 
complications when serum glucose levels are uncontrolled. Maintaining a controlled 
glycemic index requires primary care providers’ assistance and patients’ commitment 
to treatment protocols. Consistent patient education and training regarding diabetes 





complications such as hyperglycemia, acute and chronic renal failure, and chronic 
urinary tract infections. 
Summary 
DM is a chronic disease that leads to complications such as renal disease, but 
diabetes self-management education may decrease diabetes complications; early 
complications could be reversed with effective treatment plans. Developing a 
guideline that providers at the project site will use in treating diabetes patients was an 
appropriate step in managing diabetes and decreasing complications. Diabetes self-
management education involves empowering patients to take ownership of their 
health and encouraging compliance with treatment protocols. Compliance with 
treatment plans could be enhanced if health care providers establish cordial 
professional relationships with patients and encourage them to be active participants 
in their health care needs. Stakeholder involvement in diabetes self-management has a 
positive impact on the health of diabetes patients. A diabetes self-management 
guideline may improve the care rendered to diabetes patients who seek medical 





Section 2: Background and Context 
The prevalence of DM continues to increase and has triggered an urgent need 
to manage the disease and its associated complications (National center for Chronic 
Disease Prevention and Health Promotion, 2017). Health care facilities are in unique 
positions to reduce the incidence of diabetes, but efforts will require adopting 
evidence-based treatment guidelines. An important component of the guideline 
developed for this study is diabetes self-management education. It is important for 
health care facilities to adopt the most current guidelines rather than using outdated 
ones for there are many standards-of-care practices for treating diabetes, but many of 
these practices have not yielded encouraging results because of the inherent 
deficiencies (Standiford, Vijan, Harrison, Richardson, and Wyckoff, 2017). Facilities 
that do not have a diabetes care guideline empower staff to perform every aspect of 
diabetes care at the provider’s discretion, and patients have no responsibility for their 
health care needs; this approach only creates dependency and lack of patient 
ownership of the disease. Because patients are not empowered to be proactive, 
diabetes complications may continue unabated. The National Center for Chronic 
Disease Prevention and Health Promotion (2017) noted that adults with diabetes and 
hypertension or both have a higher risk of developing chronic kidney disease than do 
those without the disease, and one in three adults with diabetes might have chronic 
kidney disease, and approximately 30 million (15%) U.S. adults are estimated to have 
chronic kidney disease (CKD), 48% of those with severely reduced kidney function 
but not on dialysis are not aware of having CKD, and most (96%) people with kidney 





hours, more than 130 people with diabetes begin treatment for kidney failure. Studies 
have shown that patients who are overweight and have DM type 2 can prevent or 
delay the disease by losing 5-7% of their body weight, or 10 to 14 pounds for a 200-
pound person (National Center for Chronic Disease Prevention and Health 
Promotion, 2017). 
Diabetes complications are not limited to chronic kidney disease; many body 
organs are affected. Diabetes has been linked to the development of hypertension, 
urinary tract infection, hyperlipidemia, and hyperglycemia (ADA, 2016b). The 
relative risk of cardiovascular disease for persons with diabetes is at least double that 
of persons without diabetes (Colosia, Palencia, & Khan 2013). The purpose of this 
project was to develop a guideline to improve diabetes self-management knowledge 
through education among patients at a clinic practice site to decrease diabetes 
complications. The site staff will teach patients the necessary skills to prevent 
diabetes complications, thus empowering them. Diabetes self-management education 
is an evidence-based clinical practice that, when put into effect, decreases and delays 
diabetes complications (Standiford et al., 2017). The chronic nature of diabetes 
presents a formidable health care challenge to patients and health care providers, and 
the lack of an evidence-based guideline with emphasis on diabetes self-management 
education at the practice site may account for the increases in diabetes complications 
due to intrinsic and extrinsic factors which affects diabetes management (Rodriguez, 
2013).  
This DNP project included the concepts, models, and theories that guide the 





models and theories are relevant to the practice of nursing. The model involves 
explaining the factors that lead to self-care deficit, designing the best approach to 
promoting diabetes self-management, and tailoring the approach to specific 
individuals or groups. The project included descriptions of how nurses should teach 
patients the skills of managing diabetes to prevent or delay complications. 
Concepts, Model, and Theories 
This project entailed using a dual-theory approach to explain how self-care 
deficit could contribute to disease complications, how the patient’s perception of 
threat from the disease could lead to the patient’s desire to seek treatment, and the 
benefits of instituting the desired intervention by health care professionals. When 
patients perceive that their health is deteriorating, they may decide to seek treatment. 
Unfortunately, complications that set in may not be reversed easily when patients 
seek treatment for their chronic disease. Health care facilities and providers could 
equip patients with the necessary tools at the early stage of their disease. 
Understanding the concepts and models of patients’ behavior may help providers in 
implementing effective programs that could enhance patients’ quality of lives. 
Self-Care Deficit Model 
Appropriate models for a diabetes self-management skills program aimed at 
curbing diabetes complications are the self-care deficit model and the health belief 
model (HBM). The self-care deficit theory proposed by Orem is a combination of 
three theories consisting of the theory of self-care, the theory of self-care deficit, and 
the theory of nursing systems (Nursing Theories, 2011). Self-care refers to the 





activities patients are unable to carry out due to factors such as age, infirmity, and 
disability. Nursing systems are interventions performed on behalf of patients. 
Self-care deficit theory explains why DM complications could develop rapidly 
in some patients, and the HBM explains how patients’ perceptions of their disease 
may influence their decisions to be proactive in managing their diabetes. Love and 
Pinkowitz (2013) noted that it is important to focus on the strengths of the person 
living with the chronic disease rather than on diminished or lost abilities and 
capabilities. The main concept of the self-care deficit model is that due to certain 
therapeutic factors, patients may lack the knowledge or the skills to maintain 
optimum health or may be unable to provide self-care needed to sustain health. Health 
care professionals should step in to fulfill those roles patients are unable to perform. 
Therapeutic self-care theory includes the role nurses should play in meeting patients’ 
self-care needs when patients cannot do so effectively themselves.  
When personalized care is given to patients with self-care deficits, such as 
elderly patients with diabetes, patient satisfaction improves (Brunisholz, Briot, 
Hamilton, Joy, Lomax, and Barton, 2014). Not all patients with diabetes have the 
same ability to provide therapeutic self-care. The nurse evaluates the patient and 
determines whether he or she can administer his or her treatment plan. If patients 
have health care maintenance challenges, the nurse will facilitate family members’ 
involvement in patient care. When family members are not available, a third party 
may be needed; third parties may include friends, home health agencies, or assisted 
living facilities. A key concept in the theory is individualized patient-centered care. 





quality of life, but these complications can be delayed or prevented if the disease is 
controlled and managed (Brunisholz et al. 2014). 
The self-care deficit could occur in several ways, such as lack of 
understanding of DM pathophysiology, lack of knowledge of the effects of 
uncontrolled DM, lack of interest in diabetes management, or inability to afford 
treatment. Illiteracy and poverty can also result in self-care deficits, and in some 
cases, patients may develop complacency and treatment fatigue, which can be 
categorized as self-care deficit. Self-care deficits can also manifest differently by age, 
making it imperative to develop diabetes treatment guidelines that are tailored by age.  
Self-care deficit model could be used to teach diabetic patients to take ownership of 
their disease and participate actively in their health care needs, thereby improve the 
quality of life (Borji, Otaghi, and Kazembeigi, 2017). 
An advantage of being aware of the self-care deficit model is that it enables 
providers to identify patients’ needs, and when needs are identified, nurses provide 
the needed care. The theory of self-care deficits suggests that medical providers—
particularly nurses—should implement measures that assist patients to optimize their 
health care and that nurses should directly intervene and provide care to patients with 
self-care deficits. When self-care deficit theory is applied to the care of patients with 
DM, the outcomes are favorable in terms of providing care that DM patients cannot 







Figure 1. Orem’s self-care model. 
Health Belief Model 
The HBM is the social psychology model that is most often applied to clinical 
settings. The HBM consists of five concepts: perceived susceptibility, perceived 
severity, perceived benefits, perceived barriers, and self-efficacy (Shabibi, Zavareh, 
Sayehmiri, and Omid (2017). There are also factors that lead patients to seek 
treatment. Patients’ perceptions of susceptibility to ill health and disease, of the 
potential severity of the disease, and of the benefit of treatment are the strongest 
motivations for seeking treatment. Patients need to overcome barriers to seeking 
medical treatment, such as financial hardship and lack of health insurance, lack of 
transportation, and complacency about their health. Another barrier to seeking 





are likely to adhere to their treatment plans if they think they are getting answers to 
their questions, having their treatment options explained, and receiving assurances 
that medical intervention will cure or control their disease. The development of self-
efficacy entails self-confidence in decision-making. Health education through the 
HBM promotes self-care behaviors (Shabibi, 2017). 
A patient with diabetes who believes that the disease has no serious 
consequences and does not understand the susceptibility to avoidable complications 
such as limb amputation, blindness, and chronic renal disease may not comply with 
treatment plans. However, the HBM could be used to change patients’ behavior; the 
model is based on illness prevention. By defining health as a positive state of 
wellness, nurses can assist patients in attaining healthy lifestyles (Hendricks, 2016).  
The HBM and self-care deficit theories are complementary, and the 
combination of both theories could be synergistic to clinical practice theory and 
enhance care in a holistic manner. Although the HBM (Figure 2) is a social 
psychology model, it has relevance in nursing practice and forms the framework for 
much nursing research. The model focuses on the motivations for patients to seek 






Figure 2. Health belief model. Retrieved from 
https://www.google.com/search?safe=active&biw=1920&bih=949&tbm 
 
Relevance to Nursing Practice 
Nurses are at the forefront of primary care and therefore are in frequent 
contact with patients with diabetes; nurses at all levels of care for these patients. It is 
a duty for advanced practice nurses to apply evidence-based research findings to 
clinical settings, and diabetes self-care education has been proven to prevent or delay 
the emergence of diabetes complications. A key aspect of diabetes self-management 
education is to motivate patients to take charge of their health care needs, and one of 
the purposes of this study is to highlight the effect of motivating patients to be active 





as a means of encouraging and motivating patients to participate actively in their care 
is helpful. A recent study conducted by Chen et al. (2012) provided important 
evidence concerning the positive effect of motivational interventions in diabetes self-
management education and glycemic outcomes. The authors randomly allocated 250 
patients with diabetes to either a motivational interview group or the usual care group 
from baseline to three-month follow-up. The patients in the motivational self-
management education group achieved greater control of their diabetes than did the 
patients who received usual diabetes care by maintaining HgA1c levels below 7.0.  
Another dimension to diabetes self-management is for nurses to collaborate 
with other health care professionals in managing the disease. The goal is to maintain 
recommended serum glucose levels between 70 mg/dl to 126 mg/dl and HgA1C 
below 7.0 (ADA, 2016a). Collaboration among providers was an integral component 
of the diabetes-self management education program reported on here; for this study, I 
explored the synergistic effects of collaborative care to diabetes self-management 
education. Sieber et al. (2012) examined the efficacy of collaborative approaches in 
the self-management of patients with diabetes, noting that traditional diabetes 
education tends to suffer from low patient participation rates and is often not 
coordinated among health care team members.  
Diabetes self-management should expand beyond the traditional approach to 
include coaching patients with diabetes on a variety of health behaviors and using 
clinic based-staff who are trained to reach out to patients proactively to initiate self-
management behaviors by promoting shared decision-making. Shared decision-





management, allowing patients to take ownership of their learning processes and take 
the initiative to manage their health care needs. The role of the provider is to support, 
guide, and coach the patients in the diabetes self-management education and skills.  
The standard practices that have been used previously to address the gap in 
practice at the clinic site for this study included the health care providers’ monitoring 
patients’ glucose at the practice site rather than giving the patients logbooks so they 
can record and review fasting glucose levels. Other missing pieces of diabetes 
management are not reinforcing lifestyle changes or encouraging exercise or dietary 
modification. Patients were not taught to periodically calibrate their glucometers, 
conducting teaching physical self-examination skills was ignored, and staff decreased 
their efforts at encouraging patients to join support groups. Evidence-based diabetes 
self-management incorporates several aspects of care, and it has been shown to be 
effective in decreasing diabetes complications. Tshiananga et al. (2012) conducted a 
meta-analysis of 34 randomized controlled trials (RCTs) with a combined cohort size 
of 5,993 patients with mean age 52.8 years. The authors found that nurse-led diabetes 
self-management education was associated with improved glycemic control; the 
program was also most effective among seniors and with a follow-up period of one to 
six months. The mean change in HgA1c was reduced by 0.70% for the nurse-led 
diabetes self-management education group compared with 0.21% in the group that 
received usual care; cardiovascular risk factors also improved. The diabetes guideline 
with self-management education, if implemented at the practice site, will go far in 





Local Background and Context 
The practice site is a family medicine clinic located in a low-income 
neighborhood that is proximal to the downtown of a city in Texas and has been active 
in administering health care to the residents for over 15 years; most of the patients 
live within a 30-mile miles radius of the clinic. Most patients are beneficiaries of 
Medicare, Medical, and VA health insurance called Tricare. Most children who attend 
the clinic are on the Texas Children Health Insurance Program. The practice site staff 
consists of a physician, two nurse practitioners, a physician assistant, three medical 
assistants, front desk staff, one secretary, an office manager, an administrative 
director, IT staff, a volunteer retired registered nurse, and contract billing staff. The 
predominant ethnic group at the practice site is Latino; 90% of patients are Hispanic, 
6% are African American, 3% are Caucasian, and 1% are Asian American; most 
patients speak English but prefer Spanish. Because some patients who are not 
proficient in English feel shy to speak English, the practice site has proficient 
bilingual staff for translation. The clinic is a family medicine practice, and as such, 
the clinical staff members treat patients of all ages. DM is prevalent among the 
clinic’s patients; however, the target population is male and female patients with 
diabetes from age 30 to age 90. The practice site has no diabetes guideline, and the 
providers decide on patient treatments. My guideline with diabetes self-management 
education will ultimately help the practitioners treat patients and reduce diabetes 
complications.  
Applying evidence-based diabetes self-management education will ultimately 





are Hispanic, although a sizeable number are African American. Office of Minority 
Health (2016) statistics indicate that Hispanics are 1.7 times as likely as non-Hispanic 
Whites to be diagnosed with diabetes and are 40% more likely to die from diabetes 
than non-Hispanic Whites. Latinos also have higher rates of end-stage renal disease 
caused by diabetes. In 2010, Hispanics were three times more likely to start treatment 
for diabetes-related end-stage renal disease than were non-Hispanic Whites. In 2010, 
Hispanic women were 1.5 times as likely as non-Hispanic White women to die from 
diabetes. 
Many Latino dishes feature staple foods like beans, rice, and tortillas, all of 
which are high in carbohydrates (Olga, 2017). In addition, many Latino, including 
African American, foods are prepared using cooking methods that add unhealthy 
amounts of fat and salt. Many Hispanic meals could be prepared in nutritious ways 
without losing the flavor or the cultural composition. Food choices should be 
discussed during dietary counseling with patients. Specifically, care staff should be 
encouraging patients to make food substitutions such as substituting lean poultry for 
beef, brown rice for white, and wheat bread for white; eating larger portions of 
vegetables and fewer carbohydrates; and increasing their water intake. Patients tend 
to comply with treatment when they see its benefits in terms of fewer diabetes 
complications. 
There is no physical activity designed specifically for patients with diabetes 
patients, especially elderly patients; however, physical activity has been shown to 
improve glycemic index and prevent diabetes complications. Physical activity does 





the park or around the neighborhood may be sufficient to keep diabetes under control. 
Patients with a physical disability should be encouraged to engage in kinesthetic 
exercise as tolerated, weight lifting, and body building are also acceptable physical 
activities that diabetes patients should be encouraged to perform. There are 
community parks and recreational centers around the clinic project site, but few clinic 
patients that take advantage of these amenities. The care providers at the site do not 
encourage the patients to be physically active, and diabetes support group 
membership is low because providers do not refer the patients to the support group 
and the patients are not motivated to join the diabetes support group.  
There are no known national, regional, or community laws that mandate 
health care practitioners to test diabetes patients’ glucose levels, and there are clearly 
no laws that mandate practitioners to educate patients on how to manage their 
diabetes. At the clinic site for this study, care providers follow their own individual 
care models. Practice guidelines are not laws, but it is prudent for clinicians to follow 
evidence-based guidelines in providing care to patients. 
Role of the DNP Student 
Nursing as a profession requires the input of students, health care providers 
such as nurse practitioners and physicians, and allied health care staff in designing, 
implementing, and evaluating programs aimed at keeping patients healthy and safe. 
DNP students can expand the scientific basis for patient care (Association of 
American Colleges of Nursing, AACN, 2006); they could be agents of change by 
staying current with the latest research findings and determining how best to apply 





knowledge from various disciplines to enhance and improve health care outcomes for 
patients. A DNP student may take the initiative to teach and coach patients on aspects 
of diabetes self-management that decrease, delay, or prevent the emergence of 
diabetes complications, although even after complications occur, steps can be taken to 
reverse or stabilize the condition. 
The AACN (2006) stipulates that DNP students should focus not only on 
direct patient care but also on the needs of panels of patients, target populations, and 
broad communities. DNP students should also contribute their knowledge in 
improving nursing practice by demonstrating competence in quality improvement 
strategies and addressing the practice problems in view of new discoveries in nursing 
practice (AACN, 2006). DNP students can assess the risk to patients of 
unconventional nursing practices, identify system-based issues that need rectification, 
and discourage practices that do not facilitate safe care delivery.  
A DNP student is a patient advocate; the advocacy role include advocacy for  
the nursing profession within the policy and health care communities and educating 
others, including policymakers at all levels, regarding nursing, health policy, and 
patient care outcomes (AACN, 2006). Nursing students teach patients basic skills of 
health maintenance; as it relates to diabetes and preventing complications, this role 
entails advocating diabetes self-management education because diabetes self-
management is an evidence-based program that decreases or prevents diabetes 
complications. DNP graduates should be teaching patients skills such as glucometer 
calibration, how and when to check serum fasting glucose levels, administering 





examinations, modifying diet and lifestyle, increasing physical activity, and joining 
support groups. The DNP graduate’s role could be summed as providing clinical 
leadership by designing and implementing practice guidelines, mentoring personnel, 
and educating patients. 
Role of the Project Team 
Effective teamwork is an essential component for the delivery of high-quality 
patient care in increasingly complex medical environments, and effective practice 
teams depend on improving teamwork, increasing organizational care processes, and 
decreasing risk of care staff burnout (Deneckere, Euwema, Lodewijckx, Panella, 
Mutsvari, Sermeus, and Vanhaecht, 2013). Creating an interdisciplinary team with the 
right professional skills is vital for the successful execution of the diabetes self-
management developed for this study. The team members assumed specific roles 
based on their skills, and the team’s collaborative duties were divided into small units 
for efficiency and accountability. The team comprised me as the team leader, a nurse 
educator, an administrator, the secretary, the information technologist, and the 
medical director for purposes of reviewing the guideline that will be developed. The 
team met two to three days a week on Monday, Wednesday, and Friday evenings at 
the end of the regular duties so as not to disrupt clinic operations. Regular meetings 
afforded us opportunities to share expertise knowledge, deliberate on evidence 
findings, and give input on the project. The team members’ duties were as follows: 
• As a project team leader, I led, directed, and approved team activities. The 
activities included initiating the diabetes self-management education in the 





and expert opinions on the diabetes self-management program education 
as well as assessing the impacts on patients from the program. Other team 
activities involved writing the diabetes self-management guideline as well 
as developing the implementation strategy including how to present the 
guideline to the stakeholders. I developed the curriculum for orienting the 
clinic’s allied health care staff setting and the teaching methodology for 
improving patients’ skills at self-management of their diabetes. I 
established evaluation criteria that assessed the planning, implementation, 
outcome, and effectiveness of the program.  
• The nurse educator’s duty, once the guideline is approved, will be to 
educate and train the staff on the diabetes self-management education 
process and supervise the self-management education. The goal is to teach 
patients the skills needed to prevent or reverse acute diabetes 
complications. 
• The office administrator sent out the meeting schedules to the team 
members and organized the meetings. The office administrator also 
participated in the project team’s decision-making process and invited 
interested stakeholders to attend the meetings as observers. 
• The secretary typed the project team’s documents and keep track of the 
team’s memos. 
• The IT staff member provided computer troubleshooting and will prepare 
the PowerPoint presentation for the stakeholders. This role also includes 





will contain the evidence-based guideline, protocol, and the project team’s 
administrative strategy. 
• The medical director is a physician who acted as a consultant to the design 
and implementation of the diabetes self-management education program. 
The medical director was responsible for validating the medical 
information and provided valuable medical information to the project. The 
medical director also participated in the project evaluation process.  
Summary 
The clinic practice site for this DNP project does not have guidelines on how 
to treat diabetes patients including decreasing the prevalence of diabetes 
complications, and because there are no guidelines, providers choose their own 
treatment methods. The increasing prevalence of DM complications has necessitated 
a need to develop and implement a diabetes guideline that includes diabetes self-
management education at the practice site. Diabetes self-care management education 
has proved to be effective in managing diabetes and reducing the associated 
complications. The self-care deficit model may explain factors that contribute to 
diabetes complications, and the HBM explores patients’ motivations to seek 
treatment. DNP students have a unique role to play in the maintenance of diabetes 
patients’ health, including teaching patients needed self-management skills to 





Section 3: Collection and Analysis of Evidence 
The purpose of this evidence-based project was to develop a guideline to 
improve patients’ diabetes self-management knowledge at the practice site; providing 
care to patients using an evidence-based guideline that improves patients’ health 
outcomes. To conform to the advanced standard of practice, the practice site needs to 
have a guideline that ensures that patients with diabetes are getting the best available 
treatment (Barcelo, Muzamil, and Qiang (2017). Increasing providers’ and diabetes 
patients’ awareness of evidence-based diabetes management may prevent or delay 
complications, and for patients who are already experiencing complications, an 
evidence-based diabetes self-management program at the project site may delay the 
progression of these complications and may possibly reverse them (Chrvala, Sherr, 
and Lipman, 2016). 
The practice site has many patients with diabetes complications that resulted 
from the clinic’s lack of a diabetes treatment protocol and from not encouraging 
patients to take ownership of their health care needs. The treatment failure at the 
practice site is evident, with 75% of diabetes patients having HgA1C above 7.0 and 
manifesting macrovascular and microvascular complications. A treatment protocol 
grounded in sound nursing theory, tested by research, and supported by evidence is 
needed to close the gap in practice at the project site and alleviate the frequent 
diabetes complications that affect patients. Researchers have conducted many studies 
on diabetes self-management, and the findings have supported that diabetes self-
management reduces complications and empowers patients to take charge of their 





2012; Tsiananga et al., 2012). I provide here an extensive literature review in Section 
3; I present sources of evidence for this doctoral project, practice-focused questions, 
and analysis and synthesis of the data. Successful implementation of the diabetes self-
management program to decrease complications at the project site may motivate other 
clinics in the community to adopt a similar program. 
Practice-Focused Questions 
The project site has no defined protocol or guideline for treating diabetes; 
instead, the providers at the facility use their own discretion in instituting the 
treatments they deem appropriate. When complications arise, the providers scramble 
to find solutions. For example, there is no treatment plan for patients with chronic 
kidney disease stage 3 with estimated glomerular filtration rate (eGFR) of 30 until the 
patients develop stage 4 disease with eGFR below 30 and end-stage renal disease. 
The providers are supposed to institute a treatment plan at stage 1 of the kidney 
disease to try to stop the disease progression.  
An established standard of diabetes care through a diabetes self-management 
program is important to prevent diabetes complications. The first step in this 
endeavor is to teach patients how to maintain a tight glycemic index, adopt dietary 
modifications, and implement lifestyle changes. The practice-focused questions that 
guided the study were the following:  
• Will diabetes complications decrease with a treatment guideline that 
contains diabetes self-management education? 
• Will a diabetes guideline enable the health care providers at the clinic to 





• Will the providers and the patients implement their respective 
recommendations? 
• Will the practice site adopt the essential components of diabetes self-
management education contained in the guideline? 
• Will a diabetes guideline with self-management education improve 
patients’ health outcome?  
The purpose of this project was to decrease diabetes complications using a 
diabetes guideline that includes self-management skills at a community clinic. 
Developing a diabetes guideline for the clinic may result in conformity of practice 
and more consistent care. The overall goal is to improve control of patients’ serum 
glucose values and reduce diabetes complications. Giving patients control over their 
health care by training them on diabetes self-management may motivate them to be 
proactive and adhere to their treatment plans. 
Operational Definitions 
Below I define the following terms for this project:  
Cardiomyopathy. A chronic disease of the heart muscle in which the muscle 
is abnormally enlarged, thickened, and/or stiffened (Kumar, Abbas, Aster, 2015). 
Diabetes guideline. A policy or procedure to determine how diabetes is 
managed and treated (Stedman, 2013). 
Diabetes mellitus. A health condition in which the body’s ability to produce 
insulin or respond to produce insulin is impaired (Kumar et al., 2015). 
Evidence-based practice. Conscientious use of current best evidence in 





Glycemic index. How quickly foods break down into sugar in the 
bloodstream (Hall, 2015). 
Health care outcome. The health status results for patients from health care 
services or interventions (Stedman, 2013).  
Health care provider. A health care professional authorized to practice by 
the state and perform within the scope of his or her practice as defined by local, state, 
and federal laws (Stedman, 2015). 
Hyperglycemia. Elevated glucose levels usually due to prediabetes, diabetes, 
or another metabolic syndrome (Kumar et al., 2015).  
Macrovascular complication: Disease complication of any large blood 
vessel that may include the coronary arteries, aorta, and lower limb vessels (Hall, 
2015). 
Microvascular complication: Disease complication that affects small vessels 
such as the retina, kidneys, and nerves (Hall, 2015). 
Protocol: A precise and detailed plan for the study and treatment of a disease 
(Stedman, 2013). 
Renal failure: Kidney function that is below the expected parameters, which 
usually occurs in chronic diseases (Kumar et al., 2015). 
Self-management education. Education on the knowledge, skills, and 
abilities patients need for diabetes self-care (Stedman, 2013). 
Sources of Evidence 
The Walden library databases were the primary sources of peer-reviewed 





guideline that addresses diabetes self-management education and aims to prevent 
diabetes complications. Other sources of evidence included the CDC, ScienceDirect, 
the NIDDK, the ADA, the Association of Nutrition and Dietetics, and the U.S. 
Department of Health and Human Services. My search for the literature review 
centered on such sites as CINAHL, MEDLINE, Cochrane, SAGE, PubMed, and 
ProQuest. I also occasionally used Google Scholar to search for articles related to 
diabetes self-management programs.  
I identified diabetes self-management studies and related studies about 
preventing diabetes complications. The key terms I used were diabetes, diabetes 
guidelines, diabetes self-management, treatment of diabetes, and prevention of 
diabetes complications. The search was limited to 2012 to 2017 to obtain five years 
of findings from peer-reviewed articles, professional journals, and case studies. The 
research yielded 2,504 articles related to diabetes self-management. The number of 
available articles decreased to 83 after I added diabetes complications to the second 
search and to 12 when I added prevention. 
Published Outcomes and Research 
Kent, Stuart, McKoy, Urbanski, Boren, and Lipman (2013) conducted a meta-
analysis and found that complications associated with diabetes decreased with a 
diabetes self-management program. In the systematic review of risk reduction among 
patients in diabetes self-management, the authors reported that outcomes had 
improved by 79% immediately after the intervention but had reduced to 40% for 
long-term outcomes. The chronic nature of diabetes underscores the need to educate 





In another study conducted by the author, it was noted that preventive eye care for 
patients with diabetes decreased to 75% among residents in economically 
disadvantaged areas with fewer facilities that provide eye care. Diabetes is a leading 
cause of blindness among individuals aged 20-74 and the leading cause of kidney 
failure. Diabetes also confers a two to four times higher risk of stroke and rate of 
mortality from heart disease.  
A team approach to minimizing diabetes complications is advised. This 
approach involves integrating patients’ self-management behaviors with health care 
professionals’ preventive care services. An effective self-management intervention 
was shown to decrease diabetic foot complications through patients’ behaviors. 
Similarly, a multicomponent diabetes self-management training that included 
smoking cessation, eye care, and behavioral modification was shown to improve 
outcomes among patients with diabetes. The study supports patient empowerment in 
self-management education and the collaborative efforts of a multidisciplinary team. 
Van Vugt, De Wit, Cleijne, and Snoek (2013) conducted 13 RCTs on eight 
diabetes self-management interventions for type 2 diabetes. The trials involved 306 
articles. The combined total patient sample size was 3,813. By gender, 54.8% of the 
participants were female, and the average age was 57.2 years (SD 7.20); the average 
program completion rate in the study was 81.7% (SD 15.2%). Most of the participants 
were recruited from primary and secondary health care facilities. The inclusion 
criteria were diagnosis of diabetes for longer than a year, 18 years or older, fluency in 
English, and concern with web-based diabetes self-management programs. The 





diabetes self-management behavior, or only included type 1 diabetes. In the RCTs, 
five studies included patients with type 1 diabetes, and one study included patients 
who received interventions for chronic heart disease and chronic lung disease. The 
average duration of the studies was 6.69 months (SD 4.92). The assessment tools 
were patients’ Center for Epidemiologic Studies Depression Scale scores; their 
fasting blood sugar (FBS), HbA1C, COPD, CHF, and renal dysfunction; and type 1 
or 2 diabetes. The study authors found significant decreases in all the parameters and 
complications associated with diabetes when they combined diabetes self-
management intervention with behavioral changes; 77% of patients had improved 
depression, 82% had improved HbA1c values, and 45% had significant improvement 
in self-care. The intervention group experienced 82% significant improvement in 
fatigue, pain, shortness of breath, reduction in disability, and renal and cardiac 
comorbidities. Notable differences of 79% were observed between the intervention 
and the control groups in the areas of physical and diet modification. Diabetes self-
management programs when used in conjunction with behavioral change techniques 
improve the overall health outcomes and reduce the complications associated with 
DM. The limitation of this study was that there were only 13 randomized clinical 
trials. 
Tang, Sinco, Piatt, Palmisano, Spencer, and Heisler (2014) conducted a 
randomized clinical study that compared a diabetes self-management education 
program led by a peer leader with one led by a community health worker to improve 
HbA1C. The research lasted for 12 months; 116 Latino adults with type 2 diabetes 





groups participated in a six-month diabetes self-management program followed by 12 
months of monthly outreach delivered by the peer leader or the community health 
worker. Patients were assessed at 6-, 12-, and 18-month intervals. The study findings 
showed that the peer leader group achieved a reduction in mean HbA1C (8.2 to 7.5% 
or 66-58 mmol/mol), and the reduction in HgA1C was sustained at 18 months (-
0.6%) from the baseline. The community health worker group also showed reduced 
HbA1c (7.8 vs. 7.3%) including at 12 months after the intervention (-0.3%). Tang et 
al. concluded that patients in both diabetes self-management programs, led by the 
peer leader and by the community worker, maintained improved diabetes outcomes 
and fewer complications.  
Ricci-Cabello, Ruiz-Pérez, I., Rojas-García, Pastor, Rodríguez-Barranco, and 
Gonçalves (2014) showed the effectiveness of a diabetes self-management program in 
reducing diabetes complications in another meta-analysis. The researchers 
concentrated exclusively on African Americans and Hispanics in the United States. 
The authors studied 20 RCTs involving 3,094 patients and compared clinical 
outcomes for standard diabetes care with those from diabetes self-management 
behaviors. The findings of the study indicated that diabetes self-management reduced 
HbA1C by -0.31% (95% Cl -0.448% to -0.14%). The authors concluded that diabetes 
self-management education targeted at racial or ethnic minority patients did produce a 
positive effect on diabetes knowledge and on self-management behavior, ultimately 
improving glycemic control and thereby reducing diabetes complications.  
Hernandez-Tejada, Campbell, Walker, Smalls, Davis, and Egede (2012) 





primary clinics in the southeastern United States. The authors evaluated the effect of 
diabetes empowerment (a form of diabetes self-management education) on patients’ 
medication adherence and self-care behaviors. The authors conducted multiple linear 
regressions to assess the independent effects of diabetes empowerment for relevant 
covariates. The subjects were 83% non-Hispanic Blacks and 69% women, 22% were 
over 65 years or older, and 68% were not married. The authors determined that the 
diabetes empowerment had significant correlations with medication adherence and 
blood sugar testing, and the patients had overall success in managing their diet and 
reducing diabetes complications. Hernandez-Tejada et al. concluded that diabetes 
self-management was related to better knowledge, medication adherence, and 
improved self-care behavior. The authors further indicated that empowerment is an 
important factor in addressing diabetes to prevent complications.  
Brunisholz et al. (2014) conducted a retrospective analysis of adults with type 
2 diabetes who received diabetes self-management education. The purpose of the 
study was to determine the impact of diabetes self-management education in 
improving diabetes outcomes. The authors reviewed the records and data of 1,920 
type 2 diabetes patients age 18 to 75 between the years 2011 and 2012 at an ADA-
certified center in the Intermountain Healthcare facility in Utah. Three hundred 
eighty-four subjects received diabetes self-management training, and there were 
1,536 patients in the control group who did not receive the diabetes education; most 
of the participants in both groups were Caucasian. Brunisholz et al. confirmed the 
impact of diabetes self-management education on improving HbA1C at an ADA 





more likely to improve their five-part diabetes criteria bundle scores within six 
months. Subjects who received the self-management education achieved an overall 
1.36% decline in HbA1C compared with the 0.81% decline in HbA1C in the control 
group. A one percent decrease in HbA1c reduces cardiovascular disease risk by 15%, 
which is significant (Brunisholz et al., 2014).  
The findings from the above studies suggest that the diabetes self-
management education that I intend to incorporate into a clinic diabetes guideline will 
decrease diabetes complications; diabetes self-management education as part of 
treatment protocols leads to improved fasting serum glucose, HgA1c, and patient 
health. There are many variants of diabetes education, so I tailored the 
recommendations for my clinic guideline considering the demographics of the target 
patient population, such as education levels and cultural factors. 
Archival and Operational Data 
In order to know the extent of the practice site’s challenges in managing 
diabetes patients, I collected site data and found that over 75% of patients with 
diabetes had consistently high serum glucose and HgA1c above the controlled limit. 
The clinic does not keep statistical data on the patients; I was able to calculate the 
number of patients with uncontrolled glucose levels from observation and from 
reading the levels in their records from the last six months. Of 200 patients whose 
files I reviewed, 190 had fasting serum glucose levels above 150mg/dl and HgA1C 
values above 7.0%. Of those 190 patients with uncontrolled diabetes, 70% had stage 
II or III chronic renal failure, hyperglycemia, and hypertension. The site leaders 





to calculate a fair estimate of the number of patients who will benefit from a diabetes 
practice guideline. There is the limitation in the data collection that the sample of 
patients’ charts that I pulled for analysis may not accurately reflect the percentage of 
patients with diabetes at the practice site. 
Evidence Generated for the Doctoral Project 
Participants. The six clinic staff members who were included in the initial 
review of the guideline were an employed veteran physician, one nurse practitioner, a 
physician assistant, two medical assistants with bachelor’s degrees in the health care 
field, and a nonpracticing foreign medical graduate who works for the facility as a 
case manager. Five clinic staff who were included in the follow-up group are diabetes 
counselor whom patients are occasionally referred to, an endocrinologist who has his 
own clinic and who is not a practice site employee, and a physician assistant who has 
the diagnosis of DM type II; the others were the medical director, a nurse practitioner, 
and medical assistants with advanced degrees. I excluded four clinic staff members 
because they have minimal roles in diabetes management. I used the questionnaire to 
obtain the participants’ feedback on the appropriateness of the recommended 
guideline. A total of 14 questionnaires were mailed to the project participants. 
Procedures. I used the AGREE II instrument to collect the evidence-based 
data. The validity and the reliability of the AGREE II are well-known to be 
reproducible in research. After I developed the initial guideline for the clinic’s 
diabetes treatment plan including self-management education, I distributed copies to 
the initial review group along with the project overview, coursework outline, 





revisions based on the review group’s feedback, I distributed a revised guideline to a 
final review group of 15 members.  
Protections. The first step in the project execution was contacting potential 
participants and securing consent from those who met the inclusion criteria. I 
obtained written consent from the group participants indicating that they had 
voluntarily agreed to participate in appraising the guideline and offering their 
recommendations and evaluation under no coercion or force. To ensure that the 
participants’ identities were protected, I have secured all documents in a locked 
cabinet located in a secured private area in the manager’s office; the locks are coded 
and are accessible only to the team members. I strictly adhered to the Health 
Insurance Portability and Accountability Act, including using only the last four digits 
of participants’ social security numbers instead of their names and addresses. I will 
instruct the other team members to keep participants’ information confidential and 
not share it or discuss it, and not to access participants’ files unless necessary. 
Additionally, any published data and findings will not contain identifiers. The project 
site computers, as well as the privately owned computers that will be used for the 
project, have firewall, antivirus, and malware protection, and the computers are also 
password protected. 
Analysis and Synthesis 
Walden University IRB approval was required before I could execute the 
project; when I received approval, I began the project. The Walden University issued 
IRB number is 06-01-18-0435161. The data analysis followed a two-step process, 





feedback on the revised guideline. AGREE II is a tool that was developed to address 
the variability in guideline quality and to assess the methodological rigor and 
transparency with which guidelines are developed, including what information will be 
presented in guidelines and how (AGREE Consortium, 2017). The AGREE II 
instrument comprises 23 items and 6 quality domains: (a) scope and purpose, (b) 
stakeholder’s involvement, (c) rigor of development, (d) clarity of presentation, (e) 
applicability, and (f) and editorial independence. I used AGREE II to develop the 
diabetes treatment guideline for the project practice site. 
Summary 
The goal of this evidence-based project is to introduce diabetes self-
management as a standard of care in one clinic setting in a low-income community 
with the aim of decreasing acute diabetes complications at the clinic. Authors of 
several studies have demonstrated that diabetes self-management education does 
decrease associated complications. It is imperative that I convince the project site 
stakeholders to support the guideline because the clinic does not currently have any 
comprehensive diabetes treatment protocol. As a result of this lack, the clinic sees 
high prevalence of diabetes and diabetes-related complications. I developed a draft of 
a self-management education guideline, reviewed it with an initial clinic team, made 
revisions, and reviewed a revised version with a follow-up clinic staff team. In the 
next section, I discuss my findings from the two rounds of review of the diabetes self-





Section 4: Findings and Recommendations 
Diabetes patients need effective management of their chronic disease. At one 
health care facility with many providers who have varied levels of competence, I 
developed a systematic guideline with the intention of promoting consistent care for 
patients with diabetes. Before I developed the guideline, there was no protocol at the 
clinic, and providers implemented whatever practice they preferred; as a result, care 
was fragmented, inefficient, and ineffective. This lack of a diabetes treatment 
guideline could have been leading to treating diabetes patients in fragmented ways; 
patients’ glucose levels were not being controlled, and many patients have developed 
diabetes complications. 
Again, the purpose of this project was to develop a diabetes guideline that 
included diabetes self-management education to improve the clinic’s diabetes 
treatment and reduce acute complications among clinic patients. Evidence-based 
guidelines are essential in managing patients with chronic diseases; gaps in care occur 
when treatments for chronic diseases—such as diabetes—do not follow effective 
protocols (Kristensen, Nymann, and Konradsen ,2016). I conducted this project to 
remedy the lack of an evidence-based diabetes treatment guideline that would close 
the gaps in diabetes care at the clinic and improve clinic practices. Once the clinic 
leaders adopt the guideline, patients will see improved quality of life through 
controlled serum glucose levels and will be empowered to take ownership of their 
disease through diabetes self-management education. 
I obtained the evidence to support this project from the CINALH, Medline, 





diabetes complications, diabetes guidelines, and diabetes self-management education. 
In several studies, diabetes self-management education was crucial in controlling 
patients’ glucose levels and preventing or delaying diabetes complications. When 
implemented, the diabetes guideline will establish a consistent diabetes treatment 
protocol to improve patients’ health outcomes and decrease diabetes complications at 
the practice site. 
Findings and Implications 
Analysis and synthesis of the evidence indicated that practice site employees 
were eager to adopt the treatment guideline. Eight clinic employees received a 
questionnaire to evaluate the proposed guideline: a veteran physician, two nurse 
practitioners, one physician assistant, three medical assistants, and a nonpracticing 
foreign medical graduate student who works as a case manager. I did not receive the 
physician’s response in time, and one medical assistant did not respond at all; I thus 
received six responses. The medical assistant said that she had not had time to 
complete the questionnaire. The questionnaire I distributed to both the initial and final 
groups consisted of 14 questions, which are listed in Table 1. Table 2 contains the 
tabulated responses from the initial group, and Table 3 shows the responses from the 
expanded revision group. I received five responses from the latter group. Those five 
responses came from the medical doctor, a physician assistant, a nurse practitioner, a 






Initial and Follow-Up Group Questionnaire 
Question Details and Recommendations 
#1 Are the scope, purpose, and overall objective of the diabetes guideline 
clearly defined in the recommendation? If not, please provide details on 
how to improve the scope, purpose, and the objective of the 
recommendations on how to improve diabetes treatment and 
monitoring. 
#2 Are the patients’ health problems specifically described and addressed 
clearly and concisely regarding diabetes treatment and monitoring 
instructions? If the statements are confusing, please suggest how to 
amend each statement to make it better. 
#3 Did the guideline describe the target users and the population of 
patients, those with and without complications, whom the guideline is 
intended to address? Should prediabetic patients and high-risk patients 
be included in the guideline? 
#4 Does any segment of the recommendation need more clarification? If 
needed, your suggestion on how to make the guideline unambiguous 
and specific will be welcomed. 
#5 Does the guideline clearly present multiple options for diabetes 
management? Is there any evidence-based option you would like to 
include in the guideline? 
#6 Are the key recommendations in the guideline easily identifiable to all 
the staff who would be using the guideline to treat and mentor patients? 
Which recommendations should be prioritized over others? 
#7 Did the guideline contain instructions on how the treatment, mentoring, 
and monitoring of diabetes should be put into practice if approved by 
the clinic stakeholders? If not, what instructions would you like to be 
included? 
#8 Have the potential barriers such as tools, educational materials, and 
time been discussed? State how such barriers could be minimized. 
#9 Did the guideline consider potential costs to patients and the clinic of 
applying the recommendations? If not, how could cost savings be 
incorporated into the guideline? 
#10 Did the guideline incorporate concern for the health benefits, side 
effects, and risks for patients in following the guideline? If not, what 








Question Details and Recommendations 
#11 Were the views and preferences of the health care providers, allied 
health care workers, and stakeholders such as the medical director 
sought in the development of the guideline? 
#12 Are there key review criteria for evaluating how the goals set in the 
guideline can be achieved? If not, what are the parameters you would 
like to use to monitor the success of diabetes control? 
#13 Does the guideline provide for updating the recommendations to stay 
relevant and continuously improving diabetes treatment practice to 
improve patient outcomes? Send your suggestion if needed. 
#14 Are there conflicts of interest in the guideline for those who 
developed the guideline? How could such conflicts of interest be 
resolved? 
 
Overall Guideline Assessment 
 
A. Rate the overall quality of this guideline. 1, 2, 3, 4, 5, 6, 7 






Initial Group Questionnaire Responses 
Question Details and Recommendations 
#1 Are the scope, purpose, and overall objective of the diabetes 
guideline clearly defined in the recommendation? If not, please 
provide details on how to improve the scope, purpose, and the 
objective of the recommendations on how to improve diabetes 
treatment and monitoring. 
Responses 5 participants gave a rating of 7. 
1 participant gave a rating of 6 but did not give any 
recommendation. 








Question Details and Recommendations 
#2 Are the patients’ health problems specifically described and 
addressed clearly and concisely regarding diabetes treatment and 
monitoring instructions? If the statements are confusing, please 
suggest how to amend each statement to make it better. 
Responses 4 participants gave a rating of 7. 
2 participants gave a rating of 6. The participant requested the 
etiology of the development of diabetes complications to be 
explained.  
2 participants did not respond.  
 
#3 Did the guideline describe the target users and the population of 
patients, those with and without complications, whom the 
guideline is intended to address? Should prediabetic patients and 
high-risk patients be included in the guideline? 
Responses 4 participants gave a rating of 7. 
2 participants gave a rating of 6. The three participants want 
prediabetic patients to be included in the guideline. The reason 
given is that prediabetes is a precursor to the development of full 
diabetes.  
2 participants did not respond. 
 
#4 Does any segment of the recommendation need more 
clarification? If needed, your suggestion on how to make the 
guideline unambiguous and specific will be welcomed. 
Responses 5 participants gave a rating of 7.  
1 participant gave a rating of 5. The participants are medical 
assistants and did not comprehend the medication regimen and 
the classifications of the diabetes medications as contained in the 
guideline. The participant requested clarification of the 
medication classification and administration.  
2 participants did not respond. 
 
#5 Does the guideline clearly present multiple options for diabetes 
management? Is there any evidence-based option you would like 
to include in the guideline? 
Responses 3 participants gave a rating of 7. 
3 participants gave a rating of 6. The participant wanted to 
include in the guideline food potions to eat, which high-calorie 
food to avoid, and whether it is advisable to skip a meal a day as 
a measure of weight loss.  






Question Details and Recommendations 
#6 Are the key recommendations in the guideline easily identifiable 
to all the staff who would be using the guideline to treat and 
mentor patients? Which recommendations should be prioritized 
over others? 
Responses 4 participants gave a rating of 7. 
1 participant gave a rating of 6. The participants did not give a 
rationale for not scoring this section a perfect score of 7. 
1 participant gave a rating of 5. The participant wanted to know 
at what glucose level the patients should be switched from oral 
medication to insulin injectable medication. 
2 participants did not respond. 
 
#7 Did the guideline contain instructions on how the treatment, 
mentoring, and monitoring of diabetes should be put into 
practice if approved by the clinic stakeholders? If not, what 
instructions would you like to be included? 
Responses 4 participants gave a rating of 7. 
2 participants gave a rating of 6. The participants expressed 
concern that the guideline did not include implementation 
techniques. 
2 participants did not respond. 
 
#8 Have the potential barriers such as tools, educational materials, 
and time been discussed? State how such barriers could be 
minimized. 
Responses 5 participants gave a rating of 7. 
1 participant gave a rating of 6. This participant indicated that 
not enough time is available to teach patients all the 
recommendations contained in the guideline.  
1 participant gave a rating of 5. This participant stated that the 
clinic does not have enough personnel to implement the 
guideline. 
2 participants did not respond. 
 
#9 Did the guideline consider potential costs to patients and the 
clinic of applying the recommendations? If not, how could cost 
savings be incorporated into the guideline? 
Responses 4 participants gave a rating of 7. 
2 participants gave a rating of 6. The participants suggested that 
stores with the cheapest cost of supplies and equipment should 
be included in the guideline. 






Question Details and Recommendations 
#10 Did the guideline incorporate concern for the health benefits, 
side effects, and risks for patients in following the guideline? If 
not, what are the implications for the patient’s health? 
Responses 6 Participants gave a rating of 7. 
There was no dissenting response. 
2 participants did not respond. 
 
#11 Were the views and preferences of the health care providers, 
allied health care workers, and stakeholders such as the medical 
director sought in the development of the guideline? 
Responses 4 participants gave a rating of 7. These participants were aware 
of the development of the guideline and the process that was 
adopted. 
1 participant gave a rating of 6. These participants wished that 
more staff should have been involved in the process of 
developing the guideline. 
1 participant gave a rating of 5. The participant stated he was not 
aware of how staffs were consulted. 
2 participants did not respond. 
 
#12 Are there key review criteria for evaluating how the goals set in 
the guideline can be achieved? If not, what are the parameters 
you would like to use to monitor the success of diabetes control? 
Responses 4 participants gave a rating of 7. 
2 participants gave a rating of 6. The participants stated that the 
clinic should not be blamed if the key review criteria for 
evaluation of the success of the guideline if the patients are not 
compliant with the recommendations. The participants suggested 
that the key review criteria should be deleted from the guideline.  
2 participants did not respond. 
 
#13 Does the guideline provide for updating the recommendations to 
stay relevant and continuously improving diabetes treatment 
practice to improve patient outcomes? Send your suggestion if 
needed. 
Responses 5 participants gave a rating of 7. 
1 participant omitted this question. It may have been an error or 
oversight of the needed response.  








Question Details and Recommendations 
#14 Are there conflicts of interest in the guideline for those who 
developed the guideline? How could such conflicts of interest be 
resolved? 
Responses 6 participants gave a rating of 7. 
There were no dissenting participants. I believe that the 
participants knew that no conflict of interest exists in the 
guideline. 
2 participants did not respond. 
 
Overall Guideline Assessment 
A. Rate the overall quality of this guideline. 1, 2, 3, 4, 5, 6, 7 
Majority of the rating are 6 and 7 
B. I would recommend this guideline for use at the clinic. 
Yes Most participants would recommend the guideline 
No No negative response was received 
Suggested 
Recommendations 
Suggested recommendations are listed in the responses  
 
Table 3 
Follow-Up Group Questionnaire Responses 
Question Details and Recommendations 
#1 Are the scope, purpose, and overall objective of the diabetes 
guideline clearly defined in the recommendation? If not, please 
provide details on how to improve the scope, purpose, and the 
objective of the recommendations on how to improve diabetes 
treatment and monitoring. 
Responses 2 participants gave a rating of 7. 
3 participants gave a rating of 6 but did not give any 
recommendation. 
1 participant did not respond. 
  
#2 Are the patients’ health problems specifically described and 
addressed clearly and concisely regarding diabetes treatment and 
monitoring instructions? If the statements are confusing, please 







Question Details and Recommendations 
Responses 3 participants gave a rating of 7. 
2 participants gave a rating of 6 but still suggested that diabetes 
readings and recording should be done on daily basis.  
1 participant did not respond 
 
Question #3 Did the guideline describe the target users and the population of 
patients, those with and without complications, whom the 
guideline is intended to address? Should prediabetic patients 
and high-risk patients be included in the guideline? Did the 
guideline describe the target users and the population of patients 
such as patients’ diabetic patients with and without 
complications for whom the guideline is supposed to address? 
Should prediabetic patients and high-risk group patients be 
included in the guideline? 
Responses 2 participants gave a rating of 7. 
3 participants gave a rating of 6. The participants suggested that 
the scope of the guideline should be expanded to include 
prediabetic patients. 
1 participant did not respond. 
 
Question #4 Does any segment of the recommendation need more 
clarification? If needed, your suggestion on how to make the 
guideline unambiguous and specific will be welcomed. Does 
any segment of the recommendation need more clarification? If 
needed, your suggestion on how to make the guideline 
unambiguous and specific will be welcomed. 
Responses 4 participants gave a rating of 7.  
1 participant gave a rating of 5. The participant suggested that 
HgA1C needed an elaborate explanation of what it is for an 
educationally challenged patient to understand. 
1 participant did not respond. 
 
Question #5 Does the guideline clearly present multiple options for diabetes 
management? Is there any evidence-based option you would 
like to include in the guideline? Are various options for the 
management of diabetes contained in the guideline is clearly 
presented? Is there any evidence-based option you would like to 







Question Details and Recommendations 
Responses 4 participants gave a rating of 7. 
1 participant gave a rating of 6. The participant requested the 
chart of the food pyramid to be included in the guideline. 
1 participant did not respond. 
Question #6 Are the key recommendations in the guideline easily 
identifiable to all the staff who would be using the guideline to 
treat and mentor patients? Which recommendations should be 
prioritized over others? Are the key recommendations in the 
guideline easily identifiable to all the staff that would be using 
the guideline to treat and mentor patients? Which 
recommendations should be prioritized over others? 
Responses 4 participants gave a rating of 7. 
1 participant gave a rating of 6. The participant wanted to know 
if a patient’s glucose level remains below 130mg/dl and HgA1c 
above 6.0 should the patient start medication therapy.  
1 participant did not respond. 
 
#7 Did the guideline contain instructions on how the treatment, 
mentoring, and monitoring of diabetes should be put into 
practice if approved by the clinic stakeholders? If not, what 
instructions would you like to be included? Did the guideline 
contains instructions on how the treatment, mentoring and 
monitoring of diabetes be put into practice if approved by the 
clinic stakeholders? If not, what instructions would you like to 
be included? 
Responses 2 participants gave a rating of 7. 
2 participants gave a rating of 6. The participants expressed a 
desire for a robust mechanism to convince the stakeholders not 
to delay in adopting the recommendations. 
1 participant gave a rating of 5. No explanation was given. 
Perhaps, the participant did not understand the concept of the 
question. 
1 participant did not respond. 
 
#8 Have the potential barriers such as tools, educational materials, 








Question Details and Recommendations 
Responses 2 participants gave a rating of 7. 
3 participants gave a rating of 6 and suggested that all printed 
materials should be in Bilingual, which is English Language and 
Spanish language.  
1 participant did not respond. 
#9 Did the guideline took consideration of the patients and the 
clinic cost of applying the recommendations? If not, how could 
the cost savings be incorporated into the guideline? 
Responses 4 participants gave a rating of 7. 
1 participant gave a rating of 6. The participant suggested that 
patients who are unable to provide for their medical needs 
should be treated at zero cost in the clinic and be given 
pharmaceutical companies drug samples. 
1 participant did not respond. 
 
#10 Did the guideline incorporate concern for the health benefits, 
side effects, and risks for patients in following the guideline? If 
not, what are the implications for the patient’s health? 
Responses 2 Participants gave a rating of 7. 
3 participants gave a rating of 6. The participants wanted to see 
the side effects of each medication listed in the guideline.  
1 participant did not respond 
 
#11 Were the views and preferences of the health care providers, 
allied health care workers, and stakeholders such as the medical 
director sought in the development of the guideline? 
Responses 3 participants gave a rating of 7.  
2 participants gave a rating of 6. These participants were not 
aware of the development of the guideline and the process that 
was adopted. They did not know that other primary health care 
providers (MD, PA, and NP) were involved in reviewing the 
guideline. 
1 participant did not respond. 
 
#12 Are there key review criteria for evaluating how the goals set in 
the guideline can be achieved? If not, what are the parameters 







Question Details and Recommendations 
Responses 3 participants gave a rating of 7. 
2 participants gave a rating of 6. The participants stated that the 
guideline did not address the monitoring and treatment of 
prediabetes, diabetes type 1, and gestational diabetes.  
1 participant did not respond 
#13 Does the guideline provide for updating the recommendations to 
stay relevant and continuously improving diabetes treatment 
practice to improve patient outcomes? Send your suggestion if 
needed. 
Responses 2 participants gave a rating of 7. 
3 participants gave a rating of 6. Without elaboration, the 
participant wants frequent research, studies, and discussions 
about diabetes and how to find a cure. 
1 participant did not respond.  
 
#14 Are there conflicts of interest in the guideline for those who 
developed the guideline? How could such conflicts of interest be 
resolved? 
Responses 3 participants gave a rating of 7. 
2 participants gave a rating of 6. The participants are aware that 
the clinic is not funding this study and that the focus of the study 
is about the patients’ wellbeing. One participant wanted the 
names of the team members published and acknowledged in the 
guideline. 
1 participant did not respond. 
 
Overall Guideline Assessment 
A. Rate the overall quality of this guideline. 1, 2, 3, 4, 5, 6, 7 
Almost all the rating was 6 and 7 
B. I would recommend this guideline for use at the clinic. 
Yes All participants stated they will recommend the guideline to be 
adopted 
No There was no objection to adopting the recommendation 
Suggested 
Recommendations 
Suggested recommendations are contained in the participants’ 
responses. 
 
Data obtained from analyzing both the initial and follow-up groups’ responses 
to the questionnaire were essentially positive. My goal was for the project team to 





for the effectiveness of guidelines; the tool’s authors stated that users can create their 
own thresholds but advocated that high-quality guidelines should have scores above 
70% on each domain (AGREE II Consortium, 2017). Based on these scores, my 
proposed guideline is of high quality. The reviewers in both groups rated the 
guideline as meeting the criteria for implementation at the clinic and endorsed its 
adoption. Table 4 shows the questionnaire numbers, and Table 5 shows the domain 
scores as percentages. 
Table 4 




Corresponding Domain Item 
Numbers 
Scope and Purpose 
Questionnaire Number 








3, 4, 9, 10, 11,12, 13, 
and 14 
Item Number 7, 8, 9, 10, 11, 12, 




4, 5, and 6 Item Number 15, 16, and 17. 
Application  
Questionnaire Number 




13 and 14 Item Number 22 and 23. 
Overall Guideline 
Assessment 1 Questionnaire Not Applicable 
Recommend this 
Guideline for Use 1 Questionnaire Not Applicable 
 
Table 5 shows the percentage score from each domain to indicated how the 






Score on Each AGREE II Domain  
The Domain Score of the Domain 
Scope and Purpose 91.11% 
Stakeholder Involvement 92.22% 
Rigor of Development 91.16% 
Clarity of Presentation 95.55% 
Application  92.50% 
Editorial independence 91.67% 
Overall Guideline Assessment Positive 
Recommend this Guideline for Use 100% 
 
One unanticipated limitation in my analysis was that despite the enthusiasm of 
the clinic staff about the project, not all questionnaires were returned on time. Two 
participants in the initial group and one in the follow-up group did not return their 
questionnaires, and thus their data were excluded from my analysis. I faced strict time 
constraints that forced me to stop collecting data at a certain date, and data I could not 
incorporate might have changed the overall ratings. It is possible that staff members 
were complacent about completing their questionnaires or that they did not realize my 
time constraints or that missing data might affect my results. Staff members might 
also have felt actively or passively resistant to the idea of the guideline and thus been 





The sample size of the project was small, and because some participants were 
excluded, the accuracy of my findings in terms of the project team’s evaluation of the 
guideline might have been diminished. My analyses and conclusions might have been 
negatively affected by missing data from the diminished input of the excluded 
participants. Separately, I limited my guideline evaluators to clinic staff, whereas 
involving the broader group of stakeholders could stimulate the desire to implement 
the new guideline at the clinic. 
The strength of the project is the thorough responses I did get from the six 
initial review group members who completed their questionnaires in time. Both the 
initial and the follow-up review groups comprised individuals who are professional 
health care staff and who have regular encounters with diabetes patients. The non-
health care providers contributed knowledge from the layperson’s point of view and 
gave suggestions on how to improve the wording and format of the diabetes self-
management education curriculum and the design of the guideline. The initial group’s 
responses assisted me in refining the guideline and contributed to the final version. I 
used the broader follow-up group’s responses to appraise the guideline for quality and 
effectiveness.  
The potential implications for positive social change from this project are that 
it will allow the clinic staff to provide efficient and effective diabetes treatment, 
reduce diabetes complications, and improve patients’ health outcomes. Health care 
providers will be able to effectively control patients’ serum glucose levels and 
HgA1C. The diabetes self-management education will also encourage patients to be 





diabetes and decrease complications, and encourage patients to take ownership of 
their diabetes. The guideline will encourage the health care providers to be conscious 
of their diabetes treatment practices and concerned about the way they provide care to 
the patients. With the guideline, the providers will have guidance in teaching and 
monitoring clinic patients on the much-needed skills of diabetes management. 
Overall, the guideline will improve the treatment of diabetic patients at the clinic. 
Recommendations 
The rising prevalence of diabetes type II and the associated obesity pose a 
significant threat to the population of this clinic’s community. In conjunction with 
genetic predisposition, economic and social factors act as substrates to enhance the 
likelihood of DM type II. Recommendations are aimed at the modifiable factors that 
contribute to diabetes onset among the patients at the practice site. Recommendations 
will be important for guiding the treatment of clinic patients with diabetes; the 
recommendations complement each other and are all important.  
However, the first recommendation for any diabetes patient is weight control; 
there is compelling evidence that excessive carbohydrate intake has important 
influences on metabolic syndrome, obesity, and type 2 diabetes (Slyper, 2013). It is 
also well-known that diabetes type II is associated with obesity, and the factors that 
lead to obesity need to be addressed with each diabetes patient. Multiple approaches 
are needed to combat obesity, although the three most significant contributors are 
overconsumption of calories (especially carbohydrates), inactivity and sedentary 
lifestyles, and lack of exercise. Obesity is also linked to other diabetes complications 





Weight control has multiple effects on improving the health outcomes of 
diabetic patients; patients who lose weight often achieve improved serum glucose 
levels that could let them discontinue their diabetes medications, improved HgA1C, 
and decreased frequency of hyperglycemia. In the context of the guideline I 
developed for this study, the providers will discuss weight control measures for 
patients with body mass index above 25. Weight control measures include:  
Dietary modifications. Patients should (a) decrease fat intake and decrease 
portion sizes; (b) use the plate method to guide food choices and portions through the 
day; (c) avoid fried foods or foods with excess saturated fat and cholesterol, (d) use 
less added fat, sugar, and salt; (e) use alcohol sparingly and only after discussing the 
effects with a care provider (this includes never drinking on an empty stomach 
because this can cause blood glucose to be too low); (f) drink adequate water or 
sugar-free beverages and avoid sugared drinks; (g) eat high-fiber foods such as 
vegetables, fruits, whole grains, and beans; and (h) try to distribute carbohydrate 
intake evenly throughout the day (Department of Veterans Affairs and Department of 
Defense, VA/DoD, 2017). 
Exercise. Providers should discuss with the patients exercise regimens that 
include cardiovascular, weight-bearing, and aerobic exercise for 30 to 45 minutes at 
least three times a week; however, providers should caution patients not to exercise 
when their serum glucose is too high or too low to avoid a hypoglycemic episode. 
Brisk walking, flexibility, and kinesthetic exercises are alternatives to more vigorous 





Glucose monitoring and equipment calibration. Patients who are newly 
diagnosed with diabetes should be taught how to monitor their serum glucose with a 
glucometer at home. The ideal frequency for checking is before all meals, but the 
minimum frequency should be once a day before breakfast. Patients with long-term 
diabetes should receive periodic reinforcement of their self-care skills including being 
reminded to be proactive in their serum glucose monitoring. Patients should also be 
taught and encouraged to calibrate their glucometers to ensure accuracy in glucose 
measurement.  
Recording serum glucose levels on a log sheet. All diabetes patients should 
receive one of the clinic’s log sheets to record their serum glucose levels. The 
importance of recording the readings is that it provides the patients a visual means of 
tracking their glucose. Patients can identify trends and adjust their diets, exercise 
regimens, or medication regimens as needed. Patients should also bring their logs to 
each office visit for review with providers.  
Medication therapy. The drug of first choice to treat all diabetes should be 
metformin, although metformin should not be initiated if a patient’s eGFR is between 
30 and 45, and it is contraindicated when eGFR is below 30. Depending on the 
patient’s serum glucose level, the starting dose should be low, 500 mg daily; 
providers adjust the medication in accordance with the patient’s serum glucose. When 
HgA1C is above 7.5% and premeal serum glucose levels are above 130 mg/dl after 
three months of monotherapy with metformin, dual therapy is necessary. Dual 
therapy should consist of metformin and a sulfonylurea such as Amaryl or Glucotrol 





GLP-1 receptor agonist. Providers should initiate triple therapy after three months of 
dual therapy without any significant improvement in the patient’s serum glucose or 
HgA1C. Triple therapy consists of metformin, the dual therapy medication, and 
insulin. Patients have the option of combination injectable insulin (long or short 
acting) with GLP-1 receptor agonist depending on their preference and their serum 
glucose data; short-acting insulin is added if the long-acting drug is not working. 
Providers can also begin insulin therapy with patients who have not maintained 
glycemic control even after months of double or triple oral hypoglycemic agents and 
with patients with FBS 250mg/dl, HgA1C above 10, or ketonuria (ADA, 2016). 
Adjuvant medication therapy. Diabetes patients benefit from measures that 
protect other organ systems. A low dose of an ACE inhibitor such as lisinopril or an 
ARB such as losartan protects the kidneys from oxidative damage and provides 
renovascular protection. Low-dose statins such as simvastatin lower serum lipid 
levels and prevent atherosclerotic vascular disease in patients with diabetes and 
adding low-dose aspirin (81 mg daily) offers cardiovascular protection as long as 
there are no contraindications (ADA, 2016).  
Collaboration. Patients’ health status should be continuously evaluated. 
Providers should make referrals to allied health professionals and specialists when 
doing so is in the patient’s best interest. Providers can make referrals to a diabetes 
counselor when, for instance, they are not able to teach patients the necessary self-
care skills, and annual referrals to specialists may be warranted for patients with 
eGFR below 30 (CKD stage 3). Annual referrals to ophthalmologists are also 





treatment before it advances. Care providers should also examine patients’ feet at the 
office and refer patients to a podiatrist if there are any foot abnormalities. 
Cardiologists should also be part of the referral team if a patient has any associated 
cardiac pathology.  
Coping skills. Providers should evaluate patients’ coping skills at every 
patient-provider encounter. For elderly patients with limited skills, providers should 
encourage family members or other trusted people to participate in patients’ care with 
their consent. Providers should also encourage patients to participate in community 
support groups, although this should not be mandated. In the clinic vicinity, support 
groups are available at the local ADA chapter and other health care facilities.  
Keeping follow-up appointments. Providers should ask patients if they face 
any barriers to coming to the clinic or otherwise participating in their care, such as 
transportation and affordability. Providers should explore available resources in the 
community that could offer patients the needed assistance, including giving patients 
medication coupons and samples.  
Diabetes self-management education. The key to patients’ managing their 
diabetes is educating them frequently on self-management skills; even when patients 
know the skills, it is beneficial to reinforce them, particularly when new evidence or 
materials are available. Mentoring and teaching are the foundations of effective 
diabetes self-management. As noted above, providers should encourage patients to 
monitor their own serum glucose and HgA1C values and ensure that they are aware 





Patients also need to know about medication side effects such as 
hypoglycemia. They should be taught to eat immediately when they start to feel the 
signs of hypoglycemia such as excessive sweating, fainting sensation, and trembling. 
Providers should also advise patients to eat when their serum glucose is less than 
60mg/dl and to call their primary care providers if serum glucose is more than 250 
mg/dl. Diabetic ketoacidosis rarely develops when FBS is less than 250 mg/dl 
(VA/DoD, 2017). Patients should also seek medical treatment if they are feeling the 
signs of hyperglycemia such as excessive thirst, frequent urination, and malaise. 
In addition to side effects specifically, patients should know when to take their 
diabetes medications. For example, sulfonylureas are better absorbed on an empty 
stomach and should be taken 30 minutes before meals, whereas short-acting insulin 
should be administered at the time of meal consumption to avoid hypoglycemia. 
Patients should receive guidance on insulin administration and injection sites, 
including knowing to rotate injection sites to avoid scar tissue formation that could 
decrease insulin absorption. Patients should know how to examine themselves and be 
aware that they should report any wounds especially to the lower extremities; lower 
limb amputation is a frequent complication of diabetes.  
Involve patients in all aspects of their care. Involving patients in their care 
ensures compliance and encourages patients to take ownership of their disease and be 
proactive in meeting their health care needs. Displaying information visually such as 
with charts, graphs, and posters solidifies patients’ knowledge and reinforces their 
involvement in their care. Providers should request feedback and ask patients to 





address patients’ emotional needs and provide support and encouragement for their 
involvement in their diabetes care.  
Providers should also avoid confusing medical jargon and instead use simple, 
understandable language. For instance, patients may not understand what HgA1C 
stands for or recognize what levels are too high. Providers could, for example, tell a 
patient that her three-month blood sugar values are above the control of 6.4 rather 
than just telling her that her HgA1C is 7.0.  
Use translators to communicate with patients when necessary. For patients 
who are not fluent in English, providers should attempt to communicate the guideline 
in the patient’s primary language. Providers should not hesitate to use interpreters to 
communicate effectively with patients. Although this should be avoided, if there is no 
interpreter, Google Translate and similar applications are available.  
Cost control measures. Providers and allied health staff should recommend 
to patients that they buy supplies such as alcohol pads, glucometers, strips, and 
lancets at stores that offer low prices and/or discounts; patients should also receive 
samples from the clinic when they are available. Staff can also help low-income 
patients by helping them enroll in subsidy programs. Additionally, if patients cannot 
afford HgA1C monitoring every three months, they could monitor every six months. 
 Establish control parameters. Patients with HgA1c above 6.5 and/or FBS 
above 126 mg/dl should be considered diabetic, although HgA1C between 6.5 to 7.0 
is considered controlled diabetes. Providers should initiate medication therapy for 
HgA1C above 7.0, which indicates uncontrolled diabetes. Patients with lifetime 





expectancy of less than 5 years of HgA1C from 8.0 to 9.0 could be used establish 
controlled parameter (VA/DoD, 2017).  
Updating the guideline. The guideline I developed for this project will be 
reviewed periodically and is subject to change. Changes will be made in accordance 
with new credible, evidence-based findings from experts such as the ADA and the 
American Association of Clinical Endocrinologists. 
Proposed Secondary Products 
I propose a food pyramid chart (Appendix C) to supplement the primary 
diabetes care guideline. The chart will help patients with measuring appropriate 
portions of the correct foods and choices of food combinations. I also propose a 
picture of insulin injection sites (Appendix D) because many patients may not know 
the appropriate sites. Providers should also teach patients how to administer insulin 
and also to rotate their injection sites. A visual aid (Appendix E) will be educational 
and will reinforce the verbal instructions patients receive. It is also important to 
ensure that patients understand the pathophysiology of the pancreas and the etiology 
of diabetes mellitus, also with a visual representation of the pancreas (Appendix F). 
Recommended Implementation and Evaluation Procedures 
The diabetes guideline will need a system of implementation and evaluation at 
the practice site; the best way to implement the guideline is to educate the clinic staff 
members, beginning with an in-house seminar with the staff about the content of the 
guideline, what it is intended to achieve, and its expected impact on the patients’ 
health. The second step is to conduct simulation tests to supervise different staff 





management skills. Implementation is usually challenging when new practice 
standards are introduced.  
 The recommended implementation will be to train the practice site medical 
assistants on mentoring on how to conduct glucometer quality control checks and 
how to record their glucose levels in the log book, as well as to cordially remind 
patients about the frequency of diabetes home monitoring. The clinic’s health care 
providers should be responsible for the bulk of the implementation. I will recommend 
that the providers assess patients’ diabetes knowledge and correct any 
misinformation. Patient education is the key to successful implementation of the 
diabetes guideline.  
 I will also recommend that the clinic providers follow the evidence-based 
medication regimen that I discussed in the recommendations section earlier in this 
study and that I will include in the diabetes guideline. Providers should also review 
patients’ medication administration along with covering adverse effects; medication 
review will let the providers know if patients are compliant with the medication 
regimen. Also, as part of the guideline’s implementation, providers should emphasize 
physical exercise and dietary modification equally, including providing patients with 
the locations of community recreation centers and encouraging them to exercise 
regularly, at least three times per week. Providers should also administer preventive 
health check-ups such as annual eye examinations, podiatry care, and diabetes 
education, along with making timely referrals to specialists such as nephrologists, 
cardiologists, wound care specialists, neurologists, and ophthalmologists at any 





 Evaluation. Evaluating the guideline will require determining the impact of 
the project. Evaluation will entail collecting patient feedback about the program along 
with specialists’ reports, checking patients’ glucose logs, and assessing their serum 
glucose and HgA1C levels; one way to evaluate the effectiveness of the diabetes 
guideline will be is to monitor patients’ HgA1c every three months and compare the 
values over time. Frequent health assessment (twice annually) will enable the clinic 
providers to evaluate patients’ health and collect data. 
Separately, patients should receive satisfaction surveys every year or two 
years to rate their experiences and treatments at the clinic practice site. The guideline 
will be considered effective if most of the patients show recommended HgA1c values 
of 5.8 to below 7.0 and maintain fasting serum glucose between 60 mg/dl to 126 
mg/dl, if fewer patients develop diabetes complications, and if most patients’ surveys 
indicate significant improvement in their health status.  
Individual staff performance should be evaluated to determine if the clinic 
staff personnel are meeting the implementation targets such as controlled serum 
glucose and HgA1c levels. There should be monthly peer reviews to ascertain if the 
staff are complying with the established diabetes treatment criteria. Staff members 
should also evaluate the guideline itself periodically to determine if updates are 
needed; among other areas, any evaluations of the diabetes guideline I have 
developed should include incorporating any new evidence-based findings regarding 
diabetes treatment. The primary goal of the evaluation is to inform the practice site 





Contributions of the Project Team 
The project team consists of the team leader, a nurse educator, an office 
administrator, a secretary, an information technologist, one health care medical 
assistant, a nurse practitioner, and the medical director. The team’s work on the 
project to refine the diabetes guideline I developed was dynamic. The team met on 
Mondays, Wednesdays, and Fridays shortly after the last patients had left. As the 
team leader, I prepared the agendas and introduced the progress. Each member 
deliberated on the agenda and contributed his or her expert opinion to resolve any 
oversight issues. 
The two teams held detailed discussions on the questionnaires, including their 
feedback and suggested amendments; members deliberated on the proposed changes 
to the diabetes practice guideline recommendations based on supportive evidence 
such as research, studies, and expert opinion. Among the issues that came up during 
deliberations were the following: 
• Which recommendations would take priority? 
• Would the clinic staff have sufficient time to teach patients the basic 
diabetes management skills? 
• How often should HgA1c be ordered? What is the ideal frequency of 
patients’ follow-up visits? 
• What would be the costs to the patients and the clinic if the clinic adopted 
the diabetes self-management education guideline? 
The team resolved by joint decision-making that the providers should 





management skills. Every effort should be made to refer patients to diabetes 
educators when the clinic providers do not have the time to teach patients what they 
need to know. Another resolution the team reached was to measure HgA1c every 
three months for patients with uncontrolled diabetes and every six months for patients 
with controlled serum glucose and HgA1c levels. Follow-up care should be scheduled 
for two to three weeks after laboratory tests are taken and every time a medication 
changes. Health care needs should be individualized, particular for self-pay patients 
in order to decrease health care costs. Meanwhile, the clinic’s costs of implementing 
the diabetes treatment guideline will be offset by improved treatment practice and 
patient health outcomes. 
Team Members’ Responsibilities 
I as the team leader organized the project, communicated the project 
objectives, and designed the project. Specifically, I developed the diabetes guideline, 
the recommendations, and the questionnaire. I presented the recommendations to the 
team members and reviewed the responses and the feedback. The nurse educator 
emphasized the crucial role of educators in teaching and mentoring patients as well as 
serving as resources for both the patients and the health care providers. The nurse 
educator reviewed the diabetes guideline and ensured that the guideline contained an 
adequate teaching component. The office administrator scheduled all the team 
members’ meetings, typed the guideline and all memos, and helped arrange the 
sequence of information. The IT specialist made computers and other electronic 
media available for the team members, the medical assistant recommended that 





provider contributed to the medication administration regimen, ordered laboratory 
tests, and determined the frequency of follow-up care. The medical director did not 
participate often due to his busy schedule, but when he did, he expressed support for 
the project and validated the importance of the diabetes treatment guideline. 
Developing Final Recommendations 
Initial group. The project team members reviewed the responses from the 8-
member initial guideline review group. I distributed eight questionnaires to evaluate 
the diabetes guideline, but two of the members did not return theirs; the physician 
indicated that he mailed had the questionnaire but then took an impromptu leave of 
absence to visit his ailing mother out of state, and one of the medical assistants said 
the content of the questionnaire was too complex. A total of six responses were 
received from the initial group. 
The questionnaire allowed respondents write in their responses in addition to 
responding yes or no to some items. I collected the data over 14 days, and I gave each 
group member my residence address, phone numbers, and email addresses in case 
there were any questions or concerns. The team made one minor revision to the 
guideline based on feedback before I sent the revised guideline to the follow-up 
group. 
Follow-up group. Five of the six follow-up review group team members 
reviewed the revised questionnaire. As with the initial group, this group had several 
methods to contact the project team members with questions and concerns. I collected 
the data from the five respondents during this round of guideline development over 





Project team. The project team members reviewed the responses from both 
the initial and follow-up groups and considered the concerns of both. The project 
team used the AGREE II instrument to score the overall quality of the developed 
diabetes treatment guideline. The project team reviewed the revised guideline over 
five days, and the medical director reviewed and approved the recommendations. The 
project team as a whole worked collaboratively, addressed concerns, reviewed 
responses, and made revisions in order to ensure a high-quality guideline. 
Plans to Extend the Project 
A study that is not disseminated does not serve a useful purpose. 
Disseminating my project will increase the awareness and the benefits of having a 
diabetes treatment guideline at the clinic. It is accepted within health care that 
clinicians and managers should base their practice and decision-making on evidence 
(Neta et al., 2015). Because this is an evidence-based DNP project, the next step in 
extending the project beyond the doctoral level is to convince the clinic leaders to 
adopt this guideline. If I communicate the initiatives in the diabetes management 
guideline to the clinic stakeholders, it is possible that there will be less resistance to 
adopting the guideline. Addressing the internal and external challenges that could 
impede guideline implementation at the project site may alleviate stakeholder 
concerns about the project. Staff members at the practice site participated in different 
groups for the DNP project; hence, these staff members may play a crucial role in the 
project’s implementation if the administrators decide to adopt the guideline. Once the 





project further will entail disseminating the project findings to the surrounding clinics 
in the community that do not have an evidence-based diabetes guideline. 
Strengths and Limitations of the Project 
Strengths 
There were no conflicts of interest; the clinic did not sponsor or finance the 
project and did not influence the project outcome. There were no financial 
transactions or gifts for the project team members and the clinic staff. Additionally, 
the staff members who assisted with the project were volunteers, and the evaluators 
acted professionally without bias. Site staff participated fully in the project and acted 
independently from any external influences. The project team utilized evidence-based 
recommendations from accredited organizations such as the ADA and the American 
Academy of Nutrition and Dietetics, and we also extracted some of the 
recommendations from the VA/DoD clinical practice DM guideline.  
I used two separate groups to assess the validity of the recommended 
guideline; group members were health care providers and end users who will be 
implementing the guideline if the administrators adopt it. The AGREE II instrument 
provided a framework for assessing the quality of the guideline and its development 
and for evaluating the guideline’s internal and external validity.  
The responses from both review groups closely mirrored each other. When the 
two groups gave similar ratings, I could deduce that the content of the recommended 
guideline was valid, standardized, and substantive; the guideline is simple to 





groups rated the guideline highly on all AGREED II domains, thus giving credence to 
the project and the guideline’s professionalism.  
Recommendations for future projects that address similar topics using similar 
methods will be to replicate the project in a clinic with similar patient demographics; 
for instance, there may be clinics in the community that do not have diabetes practice 
guidelines. Every clinic is unique, and thus, if researchers at other clinics achieve 
similar results, then patient outcomes may spread throughout larger communities 
community. I recommend that researchers identify clinics with high numbers of 
diabetes patients, assess the clinics’ diabetes treatment practices and their 
effectiveness, and develop effective diabetes treatment guidelines if the practice site 
guideline is deficient or not evidence-based. 
Limitations 
Certain assumptions were made without regard to staff comprehension of the 
recommendations in the developed guideline. Many clarifications and explanations 
were given to the medical assistants who participated in the guideline review groups; 
the issue was not reading English but understanding the content of the guideline. I did 
write the guideline in basic English, and the assistants’ difficulties with the content 
raised the issue of whether the patients who are intended to be the end users will be 
able to comprehend the guideline, particularly given that some patients may have 
limited proficiency of even basic English.  
The small sample size was also a limitation that might have affected the 
quality of this office; I had to exclude three participants because they did not return 





internal validity of studies, potentially altering the data sufficiently to render the 
project invalid. Attrition is one of the major methodological problems in any study; it 
can deteriorate generalizability of findings if the participants who remain are 
significantly different from those who drop out (Gustavon, von Soest, Karevold, & 
Roysamb, 2012). Eleven participants evaluated the guideline that I developed for this 
project, and the opinions of small participant samples may not reflect those of broader 
populations. 
I created a guideline for a diabetes self-management education regimen for a 
clinic located in a low-income neighborhood in an urban area of a city in Texas. The 
guideline may not be generalized to larger segments of the community or to other 
clinics because of the patient demographics at the project clinic, the small sample size 
for evaluating the guideline, and different staff characteristics at different clinics. As a 
final potential limitation, the stakeholders may not have the zeal to engage in further 
evaluation and implementation of the recommendations. 
Summary 
The clinic for this DNP project needs a diabetes treatment guideline to 
standardize the treatments being given to patients, and with this project, I aimed to 
develop such a guideline for the clinic. The social implication of instituting this 
diabetes treatment guideline is using evidence-based care and practices based on 
guidelines from accredited organizations to reduce diabetes complications, teach 
patients diabetes self-management skills, and empower patients to take ownership of 





Section 5: Dissemination Plan 
Disseminating this project is important for giving this and other clinics 
potential insights into managing diabetes for patients. The main purpose of 
dissemination will be to share ideas with the clinic staff members, raise their 
awareness, improve the existing diabetes management practices at the clinic, and 
implement the findings. The dissemination will include stressing the importance of 
having a standardized diabetes practice guideline rather than the clinic’s current 
approach of each provider’s choosing his or her own diabetes management practices, 
which often are not based on evidence. The dissemination will highlight the 
importance of preventing diabetes complications, implementing diabetes self-
management education, and following the recommendations from the study.  Sharing 
ideas also prevents redundant efforts through effective communication (Elium Team, 
2016). One of the most consistent findings from clinical and health services projects 
is the failure to translate findings into practice and policy. Because of failure to 
implement findings in policy, patients are unable to benefit from advances in health 
care (Grimshaw, Eccles, Lavis, Hill, & Squires, 2012). Disseminating the findings 
will be an essential role for me as the DNP scholar-practitioner. Mentoring other 
health workers through the dissemination of findings establishes me as a leader in the 
nursing profession. According to the AACN (2006), DNP students should 
disseminate findings from evidence-based practice and research to improve health 
care outcomes.  
To disseminate the findings of my project, I will use various methods. My 





presentation will include charts, posters, graphs, data, samples of the questionnaires, 
and publications that supported the study findings. The advantage of using a 
combination of verbal and visual means to disseminate the findings is that the 
audience will be able to associate the visual images with the verbal content. Visual 
images complement verbal presentations and add information to them. The advantage 
of a visual presentation is that they tend to be persuasive and convincing to the 
audience and visualization provides a powerful means of making sense of data 
(University of Minnesota, 2015). Disseminating these project findings may lead the 
clinic to adopt the diabetes guideline to decrease complications among patients, 
improve health outcomes, and improve the clinic’s efficiency at treating diabetes 
patients. 
The audience will be mostly practice site staff and stakeholders. Staff 
members will include the medical director, who is also the proprietor of the clinic; I 
will ask each staff member to attend the seminar that will be held at the practice site 
conference hall. The end users of diabetes guidelines, the health care providers and 
clinic administrators, will be invited to attend; with the permission of the medical 
director, I will invite members of the community as well. I may conduct an area 
survey of other clinics in the community that do not have a diabetes practice guideline 
or clinics with guidelines that are outdated or not based on evidence. To disseminate 
the project to the broader nursing profession, I intend to attend seminars, conferences, 
and symposia as a guest speaker. Publication of the project findings in local and 
national journals and magazines will be a viable option to reach wider audiences. My 





stakeholders, health care managers, health care administrators, and members of 
professional organizations such as the ADA. 
Analysis of Self 
As a practitioner, I have a responsibility to advance the practice of nursing, 
provide the possible best treatment to patients, and improve patients’ health. Patient 
care must be based on evidence-based treatment guidelines, educating patients on 
health maintenance skills, and empowering patients to assume ownership of their 
disease. My action is geared toward promoting strategies to address patients’ health 
care needs. The nursing profession involves developing and promoting new 
approaches to nursing practice. My development of the diabetes practice guideline 
was inspired by the desire to meet current and future needs of diabetes patients who 
attend the practice site for medical treatment, to contribute to population safety, and 
to design evidence-based interventions.  
An attribute of clinical scholarship is the use of analytical methods to assess 
an existing practice for efficiency, to determine the need to develop an evidence-
based practice, to evaluate outcomes within a practice setting, and to disseminate 
findings from studies to improve health care outcomes. After observing a deficiency 
at the practice site, I employed my scholarly skills to find a solution to improve health 
outcomes for diabetes patients who attend the practice site. My scholarship motivates 
me to function collaboratively with other allied health professionals in the knowledge 
dissemination. I intend to continue applying relevant findings for the purposes of 





I functioned adequately as the project manager. My managerial skills helped 
me coordinate staff activities and plan project events. As a project manager, I held 
each staff member accountable for completing his or her section of the project. Staff 
members were commended and rewarded with praise for accomplishing tasks. I 
employed my project managerial and leadership skills with the interprofessional team 
to create a health care guideline that, if adopted and implemented at the practice site, 
may enhance the quality of life of diabetes patients by preventing or delaying diabetes 
complications. 
A nurse practitioner’s scholarly and managerial roles are interconnected. The 
skills learned from the current project of developing a practice guideline will have a 
positive impact on planning long-term health care policies. My experience with the 
current project will lead to a more comprehensive assessment of health issues in a 
complex health care institution. I will apply diverse methodologies to implement 
health care policies based on my current experience in developing a diabetes practice 
guideline. 
 One challenge I faced during the project development was delays in the 
meetings to review the guideline; meeting at the scheduled time was challenging 
because staff members were tired at the end of the day and not always able to focus 
on the task. The other challenge was that I did not receive all questionnaires in the 
allotted time, and I had to exclude these respondents’ views from the data analysis. 
Insights gained during and at the completion of the project were enriching. 
Most of the practice staff responded positively to the guideline. Any changes in 





assistant resented the diabetes practice guideline. However, they were not opposed to 
the guideline because the patients would not benefit from the practice changes but 
because the changes would lead to more work including more paperwork and because 
it would take more time to educate the patients on diabetes self-management skills; 
the staff members feel that they are already overwhelmed with the current workload. I 
am confident that all clinic staff will come to support and implement the new 
guideline when the clinic stakeholders decide to adopt it. 
Summary 
This doctoral project was aimed at developing a diabetes practice guideline 
for a clinic that that does not have one. The goal of the guideline is to decrease 
diabetes complications, improve patients’ health outcomes, and educate the patients 
about the skills needed for diabetes self-management. The secondary goal is to 
improve diabetes management practice at the clinic. Dissemination of the study 
outcome is an important part of the project. Without dissemination, the project 
outcome may remain unknown and the knowledge gained will never be shared. 
Verbal dissemination of the study outcomes will be enhanced with visual aids. 
Hindrances encountered during the project were surmountable, and all team members 
participated actively. I remain optimistic that the diabetes practice guideline I 
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 Appendix A: AGREE II Data Domain Calculation 
Domain 1. Scope and purpose 
 
Appraiser Item 1 Item 2 Item 3 Total 
MD 6 7 7 20 
PA 7 6 6 19 
NP 6 6 7 19 
DM 
Counselor 6 7 6 19 
MA 7 7 6 20 
Total 32 33 32 97 
 
Maximum possible score = 7 (strongly agree) × 3 (items) × 5 (appraisers) = 105  
Minimum possible score = 1 (strongly disagree) × 3 (items) × 5 (appraisers) = 15  






Domain 2. Stakeholder involvement 
 
Appraiser Item 4 Item 5 Item 6 Total 
MD 6 7 6 19 
PA 7 7 7 21 
NP 7 7 6 20 
DM 
Counselor 6 7 7 20 
MA 5 6 7 18 
Total 31 34 33 98 
 
 
Maximum possible score = 7 (strongly agree) × 3 (items) × 5 (appraisers) = 105 
Minimum possible score = 1 (strongly disagree) × 3 (items) × 5 (appraisers) = 15 






























MD 6 6 7 7 6 7 6 7 52 
PA 7 7 7 6 7 6 7 6 53 
NP 7 6 7 6 6 7 7 7 53 
DM 
Counselor 6 7 7 7 7 6 6 6 52 
MA 5 6 6 6 7 7 6 7 50 
Total 31 32 34 32 33 33 32 33 260 
 
Maximum possible score = 7 (strongly agree) × 8 (items) × 5 (appraisers) = 280 
Minimum possible score = 1 (strongly disagree) × 8 (items) × 5 (appraisers) = 40 






Domain 4. Clarity of presentation 
 
Appraiser Item 15 Item 16 Item 17 Total 
MD 5 7 6 18 
PA 7 7 7 21 
NP 7 6 7 20 
DM Counselor 7 7 7 21 
MA 7 7 7 21 
Total 33 34 34 101 
 
Maximum possible score = 7 (strongly agree) × 3 (items) × 5 (appraisers) = 105 
Minimum possible score = 1 (strongly disagree) × 3 (items) × 5 (appraisers) = 15 













Domain 5. Application 
 
Appraiser Item 18 Item 19 Item 20 Item 21 Total 
MD 6 7 7 6 26 
PA 7 7 6 7 27 
NP 6 7 6 6 25 
DM Counselor 7 7 7 7 28 
MA 6 6 6 7 25 
Total 32 34 32 33 131 
 
Maximum possible score = 7 (strongly agree) x 4 (items) x 5 (appraisers) = 140 
Minimum possible score = 1 (strongly disagree) x 4 (items) x 5 (appraisers) = 20 








Domain 6. Editorial independence 
 
Appraiser Item 22 Item 23 Total 
MD 6 7 13 
PA 7 6 13 
NP 7 7 14 
DM Counselor 6 6 12 
MA 6 7 13 
Total 32 33 65 
 
 
Maximum possible score = 7 (strongly agree) x 2 (items) x 5 (appraisers) = 70 
Minimum possible score = 1 (strongly disagree) x 2 (items) x 5 (appraisers) = 10 







Appendix B: AGREE II Score Sheet 
Domain Item 









1. The overall objective(s) of the guideline is (are) specifically described.        
2. The health question(s) covered by the guideline is (are) specifically described.        
3. The population (patients, public, etc.) to whom the guideline is meant to apply 
is specifically described. 
       
Stakeholder 
involvement 
4. The guideline development group includes individuals from all the relevant 
professional groups. 
       
5. The views and preferences of the target population (patients, public, etc.) have 
been sought. 
       
6. The target users of the guideline are clearly defined.        
Rigor of 
development 
7. Systematic methods were used to search for evidence.        
8. The criteria for selecting the evidence are clearly described.        
9. The strengths and limitations of the body of evidence are clearly described.        
10. The methods for formulating the recommendations are clearly described.        
11. The health benefits, side effects and risks have been considered in formulating 
the recommendations. 
       
12. There is an explicit link between the recommendations and the supporting 
evidence. 












13. The guideline has been externally reviewed by experts prior to its 
publication. 
       
14. A procedure for updating the guideline is provided.        
Clarity of 
presentation 
15. The recommendations are specific and unambiguous.        
16. The different options for management of the condition or health issue 
are clearly presented. 
       
17. Key recommendations are easily identifiable.        
Applicability 18. The guideline describes facilitators and barriers to its application.        
19. The guideline provides advice and/or tools on how the 
recommendations can be put into practice. 
       
20. The potential resource implications of applying the recommendations 
have been considered. 
       
21. The guideline presents monitoring and/ or auditing criteria.        
Editorial 
independence 
22. The views of the funding body have not influenced the content of the 
guideline. 
       
23. Competing interests of guideline development group members have 
been recorded and addressed. 














2. I would recommend this guideline for use. Yes Yes, with modifications No 

































Appendix F: Pancreas Chart 
  
http://www.open.edu/openlearncreate/mod/oucontent/view.php?id=288&extra=thumb
nail_idp2917120 
 
